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Abstract of Dissertation
Toxoplasma gondii is an obligate intracellular pathogen. It is considered the
second deadliest foodborne pathogen in the world with up to 1/3 of the human population
estimated to be currently infected. The majority of immune competent people may
exhibit mild symptoms following T gondii infection. The acute stage of infection is often
well controlled by cellular immunity in healthy individuals. However sterilizing
immunity does not occur as the tachyzoite stage of the parasite responsible for acute
infection differentiates to a slow growing bradyzoite stage contained in tissues cysts that
can persist for the life of the host. However, if the host becomes immunocompromised,
these parasites can differentiate back to tachyzoites that can cause pneumonia, severe
central nervous system pathology and death. Current therapies are effective against the
tachyzoite stage but not the chronic cyst stage and so infected patients are susceptible to
recurrent disease should they become immunocompromised.
Apicomplexa parasites, including T. gondii have a unique family of
serine/threonine kinases referred to as FIKK kinases based on the conserved amino acids
in its active site: region of amino acid in the protein’s active site consisting of a
phenylalanine(F), and isoleucine(I), and two lysines(K). Plasmodium falciparum has 17
potential FIKK kinases while most Apicomplexa including T. gondii have a single FIKK
kinase. The goal of the current study was to evaluate the importance of T. gondii’s sole
FIKK kinase to parasite pathogenesis.
Endogenous tagging of the TgFIKK kinase with YFP followed by live cell
florescent microscopy during the parasite’s lytic cycle indicated the FIKK kinase
localizes to the parasite posterior end, within the parasite basal complex, in both

x

extracellular and intracellular parasites. It was also transiently found in the host cell
cytosol. The FIKK kinase was deleted and complemented in order to study the function
of the FIKK kinase in parasite pathogenesis. Studies comparing wild type, ΔFIKK
parasites and FIKK complemented parasites indicate that the TgFIKK kinase is not
critical for the parasites lytic cycle in human fibroblast (HFF) cells, including parasite
replication. Instead, we show that the TgFIKK kinase is critical for the ability of the
parasite to form cysts in vitro in cell culture and for the establishment of chronic infection
in mice. The deletion of the FIKK gene prevents tachyzoite to bradyzoite differentiation.
Thus, our current hypothesis is that the TgFIKK kinase may link changes in the parasite’s
cell cycle at a proposed G1 checkpoint that serves as a gateway for parasite entry into the
bradyzoite differentiation pathway.
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Introduction
History
Toxoplasma gondii (T. gondii) was first discovered in 1908 by researchers
studying Leishmania by using a rodent native to North Africa called the gundi
(Ctenodactylus gundii). Infection in the gundi only occurred in captivity while being used
to study leishmaniosis at the Pasteur Institute in Tunis (10). After discovery, the
transmission was not elucidated until 1938, when doctors in New York treated a newborn
baby girl for convulsive seizures, after one month she died, and the autopsy showed
lesions in the brain with free and intracellular parasites found upon microscopic study.
Tissue from the brain was homogenized in saline and inoculated into rabbits and mice,
which subsequently developed encephalitis (91). The parasites were isolated from the
brains of these animals and were successfully passed into other mice. Subsequent studies
showed congenital transmission in many animal species (40). In the 1960s work
demonstrated transmission by consumption of undercooked meat by feeding meat from
infected animals to children at a Paris sanatorium. A sampling of the Paris population
also showed that 80% of people were seropositive for T. gondii (17). Initial
characterization showed congenital, and foodborne transmission, however the prevalence
of T. gondii amongst strict vegetarians in India was the same as non-vegetarians (67). A
parasitologist in Scotland, Bill Hutchison, first suspected fecal-oral infection by
experimenting with the nematode parasite Toxocara cati. He fed cats already infected
with T. cati with isolated T. gondii tissue cysts. Nematode eggs isolated from the cats’
feces also caused toxoplasmosis in mice. Toxoplasma infectivity was maintained even
after eggs were stored for up to twelve months in tap water, which indicated an

undiscovered form of T. gondii since the already isolated tachyzoites, and bradyzoites
from infected brain tissue could not survive in tap water for that long (44). The final
piece of the parasite life-cycle was elucidated in 1970 when several groups independently
discovered the oocyst form of the parasite in the feces of cats (22, 31).

Classification and Natural Cycle
T. gondii is a member of the phylum Apicomplexa. This is a diverse phylum with
over 5,000 species comprised almost exclusively by intracellular parasites. T. gondii
belongs to a subset of Apicomplexa called the coccidians, a class of organisms defined by
their ability to form oocysts. T. gondii is a parasite with a wide host range and it can
infect every bird and mammal species tested (54). These species comprise the range of
animals that can play secondary host to the parasite. Secondary hosts are infected with
the asexual stages of the parasite, the tachyzoite and bradyzoite. However, the oocyst
form often transmits infection to secondary hosts though contaminated food and water.
The definitive host of T. gondii is the cat, where parasite sexual reproduction occurs. In
the cat, the parasite infects the intestine and develops into the merozoite stage that
undergoes sexual reproduction to form sporozoite-containing oocysts. The oocysts are
shed in the feces of cats. The oocysts sporulate in the environment and can remain viable
for months. Upon consumption of sporulated oocysts by a secondary host, the sporozoites
emerge and invade the small intestine, forming parasitophorous vacuoles in the epithelial
cells, and transitioning into tachyzoites (Figure 1). After replicating the tachyzoites will
egress from the infected cells, lysing them in the process. After egress the parasites
invade new cells repeating the parasite lytic cycle. The tachyzoite parasites disseminate
systemically from the intestine and can invade any nucleated cell. During infection, some
2

of the tachyzoites differentiate into bradyzoites contained in intracellular tissue cysts.
While a cell-dependent immune response typically resolves acute infection, sterilizing
immunity does not occur due to the persistence of these bradyzoites in tissue cysts. The
tissue cysts generally appear invisible to the immune response and do not generate a
noticeable inflammatory response. Thus the encysted parasite establishes a chronic
infection (54). The cysts also act as a reservoir for parasites. If a host becomes
immunocompromised, the encysted bradyzoites can differentiate back into rapidly
replicating tachyzoites and cause renewed disease. Tissue cysts may form in any
nucleated cell; however, in vivo, they are more common in the central nervous system, in
the eye, and in both skeletal and cardiac muscles (Figure 2). In vivo, bradyzoite transition
and cyst formation occur as early as one-day post-infection. Cyst size is variable
depending on the number of parasites within, and the type of host cell infected (45).

3

Figure 1: Toxoplasma gondii Life Cycle in Definitive and Secondary Hosts.
Tissue cysts are also infectious to both the definitive as well as secondary hosts through
predation/carnivorism. After ingestion of contaminated meat, the bradyzoites emerge from
the cysts, invade the intestinal epithelium, differentiate into tachyzoites and disseminate
systematically. Thus both sporozoites in oocysts and bradyzoites in tissue cysts are
infectious via oral transmission and follow a similar progression to cause disease
following their differentiation into tachyzoites.
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Infection in Humans
Humans act as a secondary host to the parasite. People are infected by the parasite
through eating undercooked meat from another infected secondary host, or by consuming
oocysts in contaminated food or water. Additionally, if a pregnant woman becomes
infected, the parasite can cross the placental barrier and infect the fetus (23).This can
result in miscarriage or congenital infection. Less likely sources of infections are blood
transfusion, organ transplantation, and contact with contaminated sharps through skin
penetration (Figure 2). Infection rates vary based on geography, and the risk of infection
generally rises with age. In the United States, overall seroprevalence is 22.5% (47).
There are three primary clonal lineages of T. gondii that are predominant in North
America and many parts of Europe: Type I, II, and III. These lineages differ in virulence
and occurrence (43). Most strains isolated from AIDS patients have been Type II, while
both Type I and II have been recorded in congenital disease cases and Type III parasites
are primarily found in animal infections (1). Replication times differ between lineages
with Type I strains replicating faster than Type II and III (66). Specific immune evasion
mechanisms also correlate with differences often conserved between parasite genotypes.
Other atypical genotypes of T. gondii exist that infect humans. These atypical genotypes
are dominant in certain areas of the world, including South America, and some have been
associated with increased disease severity.(54)
Severe clinical disease is uncommon in T. gondii infection in immune-competent
individuals. Clinical disease is more likely in immunocompromised patients and in
primary infection during pregnancy (4, 54). When symptoms do manifest in healthy
hosts, they occur within the first two weeks after infection. In these cases, the disease is
5

generally mild, non-specific, and self-limiting. Very rarely infection in healthy patients
can result in myocarditis, polymyositis, pneumonitis, hepatitis, or encephalitis (54).
In immunocompromised patients, the infection can be debilitating, and lifethreatening with most cases due to reactivation of a latent infection (62). The central
nervous system is most commonly affected by reactivated disease resulting in T. gondii
encephalitis, which can vary in presentation. Symptoms include mental status changes,
seizures, motor deficits, sensory abnormalities, movement disorders, and
neuropsychiatric findings. Often reactivated toxoplasmosis is confused with other
infections and diseases delaying diagnosis and treatment. Outside of central nervous
system (CNS) manifestations, reactivated toxoplasmosis can cause chorioretinitis,
pneumonitis, or multiorgan involvement leading to shock (62). T. gondii encephalitis is
life-threatening and requires rapid intervention to avoid fatal outcomes.
In congenital infection, the infected fetuses may appear normal on ultrasound, and
if there are findings on ultrasound, they usually are intracranial calcifications, ventricular
dilation, hepatic enlargement, ascites, and increased placental thickness (33). However,
spontaneous abortion of infected fetuses is common early in pregnancy. The presentation
of disease in newborns is variable and can include hydrocephalus, microcephaly,
intracranial calcifications, chorioretinitis, strabismus, blindness, epilepsy, physical or
mental retardation, petechia, and anemia (81). These clinical signs are non-specific and
may be caused by other infections. (54)
Treatment for toxoplasmosis is rarely given in immunocompetent individuals
unless symptoms are persistent or severe. If treatment is required a combination of
pyrimethamine, sulfadiazine, and folinic acid are administered for 2-4 weeks. Treatment
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is not required for women with prior exposure to T. gondii, as confirmed by IgG serology
as a memory response is normally capable of suppressing parasite replication and prevent
cross-placental transmission. If the infection is newly acquired, then spiramycin is given
for the first and early second trimesters, and pyrimethamine and sulfadiazine for the late
second and third trimesters (23, 33). The triple combination of pyrimethamine,
sulfadiazine, and folinic acid is recommended in immunocompromised patients.
Treatment is given pre-emptively in immunocompromised patients with suspected
reactivated infection. After resolution of symptoms, a maintenance regiment is given
using half of the dosage of the combination used in treatment. Maintenance is continued
indefinitely or until the immunosuppression has resolved (54).

7

Figure 2: Toxoplasmosis in Humans
Toxoplasmosis in humans can be acquired by various sources in the environment and the
food supply. Initial infection is often asymptomatic or mild, followed by a latency that
can last for up to a lifetime of the host. T. gondii can infect any nucleated cell in the body,
but tissue cyst forms preferentially in the muscles and nervous system.
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Structure and Lifecycle
There are three infectious stages of Toxoplasma gondii, the sporozoite, tachyzoite,
and bradyzoite. The bradyzoite and sporozoite stages are relevant to the transmission of
infection; the tachyzoite and bradyzoite stages are relevant to human disease.
The term tachyzoite comes from the Greek word for speed (tachos) and was
coined in 1973 (30). The tachyzoite is crescent-shaped, 2 by 6 micrometers with a
pointed anterior end, and a rounded posterior end. The tachyzoite cell contains a pellicle
that surrounds the cell membrane, apical and polar rings, a conoid at the apical end,
rhoptries, micronemes, dense granules, a micropore, mitochondrion, microtubules, rough
and smooth endoplasmic reticula, Golgi body, nucleus, and an apicoplast (21). T. gondii
is an obligate intracellular parasite. The tachyzoite stage is the stage that invades host
cells. Parasites only spend a short amount of time outside of a host cell, after egress,
where they move by gliding motility to find a new host. Upon contact with a host cell,
parasites adhere using glycosylphosphatidylinositol (GPI) anchored surface antigens
which recognize proteoglycans on the host cell surface (41). After binding to the host
cell, the parasite interacts more tightly with the host cell membrane; proteins are secreted
from the micronemes that lead to the formation of the moving junction (MJ), which
forms the interface between the invading parasite and the plasma membrane. The moving
junction acts as an anchor point in the membrane, using this anchor point the parasite
invaginates the host cell membrane which leads to the formation of the nascent
parasitophorous vacuole membrane (PVM) (Figure 3). During the parasite invasion, the
nascent parasitophorous vacuole (PV) forms from the host cell lipid bilayer but excludes
host cell transmembrane proteins as well as proteins in lipid rafts (75). The PVM is
9

created in a process independent of phagocytosis. The parasite invasion process and
formation of the PV creates an intracellular niche for the parasite that does not fuse with
lysosomes, preventing the host cell from degrading the parasite. This results in the
creation of a favorable PV for parasite survival and growth that is largely separated from
the host cell cytosol and the vesicular network (4). Proteins secreted from the parasite’s
rhoptries and dense granules modify the PVM and the host cell structures surrounding it
giving parasites within the PV access to the nutrients in the cytosol. Nutrients are also
acquired through recruitment of host cell organelles brought into close proximity with the
PVM that allow nutrient and lipid exchange. T. gondii is auxotrophic for key nutrients
such as tryptophan, arginine, cholesterol, and iron, and so the PVM functions as a barrier
permeable to these and other small molecules (11).
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Figure 3: Invasion and PV Formation
Invasion of the host cell by tachyzoites involves binding to the host cell membrane and
the secretion of various effector proteins that form the moving junction. The parasite
invades and secretes effectors which create the nascent PV and PV.
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Parasite replication only occurs in a parasitophorous vacuole through a unique process
called endodyogeny (49). During endodyogeny, daughter cells form within the mother
cell and upon maturation, the mother cell breaks apart releasing the new daughters
(Figure 4) (29, 73). The T. gondii cell cycle is different from most eukaryotes in only
having a G1 and S phase which is followed by mitosis with only a small G2 phase, while
cytokinesis occurs late during the S phase. Genes expressed in G1 are primarily
biosynthetic and metabolic genes common to all eukaryotes, however the transcriptome
of S/M contains genes unique to the Apicomplexa. The expression of genes during G1
also occurs in two distinct phases. The genes expressed during the early part of G1
encode for ribosomal proteins, RNA polymerases and processing factors, and proteins
needed for translation. In the second half of G1 the transcriptome becomes enriched for
genes for DNA replication and proteasomal degradation (14). Additionally quiescent
stages of the parasite, the sporozoite and bradyzoite, are considered to be in G0 (49).
The second stage found in humans is the bradyzoite stage. The name, coming
from the Greek word for slow (brady), was used to describe parasites slowly replicating
within tissue cysts (30). Structurally bradyzoites are similar to tachyzoites; the only
differences are the location of the nucleus, central in tachyzoites, closer to the posterior
end in bradyzoites, longer rhoptries, and the presence of amylopectin granules (21).
Bradyzoites have also been reported as losing the apicoplast. In contrast to tachyzoites,
bradyzoites are growth-arrested, and while considered quiescent some motility and
replication have been observed and bradyzoite egress and reinvasion is possible (25, 39).
Bradyzoites are found in intracellular cysts. In vivo cysts are most prevalent in the brain,
eye, and in skeletal and cardiac muscles (20). The smallest cysts contain two parasites
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and are about 5 µm in size, with the largest being 10-70 µm in size containing potentially
thousands of bradyzoites. In vivo formation of bradyzoites occurs as early as one day
post-infection (13).

13

Figure 4: Basal Complex and Parasite Replication
The T. gondii basal complex is important for endodyogeny, the process by which the
parasite reproduces. During endodyogeny the basal complex is one of the first organelles
formed in the nascent daughter cells, its constriction is important for the separation of the
daughter cells and their subsequent maturation. The basal complex is shown in green in
both the mother cell and the nascent daughter cells.
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The Residual Body and Intravacuolar Network
After host cell invasion and formation of the PV, the parasites replicate through
endodyogeny. During replication nascent daughter cells form within the mother cell and
release upon maturation; this leads to the breakdown of the mother cells (29). Remnants
of the mother cell remain at the posterior ends of the mature daughter cells forming a
structure called the residual body. The residual body is important for organizing the
parasites in the characteristic rosette structure within the PV (55). Membrane connectivity
exists between the residual body and the parasites within a parasitophorous vacuole until
the parasite egresses from the host cell. Additionally, the residual body is not found
within mature cysts. Consistent with the lack of a residual body, bradyzoites are not
linked together in the same rosette like pattern as tachyzoites within a PV. The
connections formed within the residual body are believed to facilitate communication
between parasites to insure synchronization within a PV. Parasite actin is important for
the formation of the residual body as conditional actin knockouts lack the structure.
These actin conditional knockouts also replicate in an asynchronous manner. Actin
polymers within the parasites were also discovered to extend into the residual body. This
actin network is important for transport of material between the parasites within a PV
(61, 82).
An intravacuolar network forms within the PV and appears to originate from the
posterior end of the parasites. However, once formed the intravacuolar network extends
throughout the PV and connects parasites within the PV to the PVM. The network
proteins are made of tubules that are 5nm thick but are more than 100nm long. The
intravacuolar network is shaped by dense granule proteins (GRAs) GRA2, GRA4, GRA6,
15

GRA9, and GRA12. Deletion of any of these proteins results in a major deficiency in cyst
formation in vivo (38, 53, 83).
Within the cyst is the intracyst network (ICN). The ICN may be a modification of
the IVN as there are similarities in its composition to the intravacuolar network that
connect tachyzoites to the PVM (71). Electron microscopy studies suggest that elements
of the ICN and cyst wall components may originate from a cytoskeletal pore in the
posterior end of parasites. These secretions lead to the formation of the network, matrix,
and wall of the cyst (Figure 7). However, dense granule proteins and rhoptry proteins are
secreted from the apical end of the parasites during invasion and are important for the
formation of both the ICN and IVN. Thus the origins and formation of the IVN, the ICN
and cyst matrix and cyst wall components remain very poorly defined (38, 71).

Tachyzoite to Bradyzoite Differentiation and Cyst Formation
Stage differentiation from the tachyzoite stage to the bradyzoite stage requires the
tachyzoite to fall out of the cell cycle and enter G0. Experiments have shown that the
transition can begin before parasite invasion of the host cell as stressing extracellular
parasites is sufficient to induce the formation of cysts after invasion (92). Bradyzoite
induction occurs at a G1 checkpoint during which time the cell commits to either
continued replication as a tachyzoite or to transition into a bradyzoite (66). Evidence
points to translational control through modification of the homolog of eukaryote initiation
factor 2 alpha, TgIF2α (90). When tachyzoites are exposed to different stressors that
induce bradyzoite transition TgIF2α becomes phosphorylated (66). Treatment of encysted
parasites using inhibitors of eIF2α dephosphorylation such as guanabenz inhibits
bradyzoite to tachyzoite differentiation. Additionally, TgIF2α is phosphorylated in
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bradyzoites (50, 56). After phosphorylation of parasite TgIF2α, translation becomes
dramatically reduced (Figure 5). This stall in protein translation allows the parasite to
reprogram its genome to respond to stress and to transition to bradyzoites. mRNAs
preferentially translated while TgIF2α is phosphorylated have been identified.
Translation of a group of transcription factors unique to the Apicomplexa transcription
factors are completely unaffected by TgIF2α phosphorylation. These Apicomplexan
apetala (ApiAp2 or just Ap2) transcription factors have an important role in regulating
the cell cycle and tachyzoite to bradyzoite transition (60). This transition between stages
is closely linked to the parasite’s cell cycle. Transition does not occur when the cell cycle
is blocked presumably because the parasite does not reach the required G1 checkpoint to
enter the bradyzoite differentiation pathway. A gene set enrichment analysis on the
parasite shows that genes associated with the S/M phase of the cell cycle are enriched in
bradyzoites, while genes enriched in G1 were found primarily in tachyzoites (13, 14).
Gene silencing is crucial to bradyzoite differentiation. In other eukaryotes gene silencing
occurs during S phase, in T. gondii initiation of bradyzoite gene expression also requires
the parasite to enter into S phase. While the timing of transition, in relation to the cell
cycle, occurs during G1 (Figure 6); the resulting changes in gene expression requires
epigenetic remodeling that occurs during S phase. Thus parasite replication and
bradyzoite differentiation are tightly linked together (65). Approximately 1000 genes are
differentially expressed in tachyzoites versus bradyzoites although few of these genes are
annotated other than as hypothetical proteins (14). Surface proteins and metabolic genes
are substantially changed between tachyzoites and bradyzoites. Canonical markers of
bradyzoites include surface antigen 4 (SAG4), bradyzoite antigen 1 (BAG1), surface
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antigen 2/2d (SAG2/2D), bradyzoite pseudokinase 1 (BPK1) and specific metabolic
enzyme isoforms lactate dehydrogenase 2 (LDH2), enolase 2 (ENO2), and enolase 1
(ENO1) (6, 8, 14, 16, 45, 95, 96, 97).

Cyst Formation and Structure
The T. gondii tissue cyst consists of the parasites within a cyst matrix that is
surrounded by a cyst wall contained within a membrane. The cyst wall is 270 to 850 nm
in thickness and is organized in two layers (84). Qualitatively, in vitro cysts are similar to
ones formed in vivo but there are clearly differences between in vitro cysts and in vivo
cysts that may undergo significant additional maturation over time (45).
The defining feature of a cyst that separates it from a PV is the presence of the
cyst wall, which forms underneath the PVM (32). Cyst walls can be detected using
various fluorescently labeled lectins. The Dolichos biflorus lectin recognizes N-acetyl
galactosamine on the glycoprotein CST1. It is used to label the cyst wall and to identify
cysts in culture (31, 95). In addition to CST1 other proteins that comprise the cyst wall
are just beginning to be identified. To date proteins in the mature cysts are dense granule
proteins: GRA1, GRA2, GRA3,GRA6, GRA7, bradyzoite pseudokinase 1 (BPK1),
microneme adhesive repeat domain-containing protein 4 (MCP4); and matrix antigen 1
(MAG1) (9, 52, 86).
The three lineages of T. gondii differ in their ability to form cysts. The faster
replicating Type I parasites are generally poor cyst formers in mice; in part because they
are almost always lethal during the acute stage of infection and the infected mice die
prior to establishment of chronic infection. However, even in vitro in cell culture they
tend to remain as tachyzoites and differentiate poorly in vitro in cyst inducing conditions.
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Type II and III parasites are better cyst formers and are less virulent in mice (43). A Type
I strain labeled RH, after the initials of the patient from which it was isolated, is the most
commonly used laboratory strain. It is easy to manipulate genetically and is primarily
parasite strain that has been studied to date to model tachyzoite biology and the parasite’s
lytic cycle in host cells in vitro. However, it is no longer able to complete the parasite’s
life cycle including differentiation to oocysts and differentiation to bradyzoite-containing
cysts (8, 43). Thus, the RH strain cannot be effectively used to study stage conversion
and cyst formation. However, under certain conditions, RH strains can produce
bradyzoite specific proteins (8).
Cyst induction and bradyzoite conversion can be studied using Type II and Type
III genotypes of the parasite. Tachyzoite to bradyzoite differentiation and formation of
nascent cysts can be induced efficiently in vitro in cell culture using a variety of diverse
exogenous environmental stresses. Bradyzoite-inducing conditions in vitro include
alkaline stress by culturing parasites in host cells in pH 8 media for approximately three
days. As an alternative a brief treatment of extracellular parasites in alkaline conditions
can be used. Other methods include treatment with sodium nitroprusside (SNP) to induce
nitric oxide (NO), arginine deprivation, incubation with mycophenolic acid, and CO 2
deprivation (8, 28, 45). While these stress conditions can be used to induce cyst
formation, cystogenic strains will spontaneously convert at low levels even in non-stress
culture conditions particularly if there is a low multiplicity of infection. Although cysts
can form in any nucleated cell, certain cell types are more conducive to cyst formation
than others (45). Cyst formation is highest in neurons and muscle cells, and cysts can
form in these cells easily even in the absence of external stressors (78). The
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permissiveness of host cells to cyst formation may be determined by the cell cycle stage
of the host cell as terminally differentiated mouse skeletal muscle cells restrict tachyzoite
replication and promote bradyzoite differentiation more than their myoblast progenitors.
The terminally differentiated state of both muscle cells and neurons may explain the
relatively greater numbers of cysts in these tissues in vivo (45, 78, 86).

20

Figure 5: Transitioning between Stages and TgIF2α Phosphorylation
Transition between stages involves numerous changes to genetic regulation in the
parasite. These changes include epigenetic changes leading to differential expression of
necessary genes, and phosphorylation and dephosphorylation of TgIF2 which affects
translation.
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Figure 6: Cell Cycle and Bradyzoite Transition
The parasite progresses through the cell cycle intracellularly inside of the PV. The cell
lacks a G2 phase with cytokinesis occurring simultaneously with S/M. At the G1
checkpoint the parasite either commits to further growth and replication, or it commits to
transitioning to the bradyzoite stage.
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Figure 7: Cyst Matrix and Wall
Graphical representation of a tissue cyst illustrating the presence of the outer cyst wall,
the inner cyst membrane, the intracyst network (ICN) and the cyst matrix
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Genetic Regulation of Tachyzoite to Bradyzoite Differentiation
The regulation of parasite differentiation between tachyzoites and bradyzoites as
well as sporozoites remains poorly understood. However, regulation of the bradyzoite
transition occurs at both the transcriptional and epigenetic levels. A series of studies have
demonstrated that epigenetics and histone post-translational modifications (PTMs) play a
vital role in protozoan parasite biology. More specifically, Toxoplasma epigenetics has
been linked with the regulation of genes expressed during oxidative stress responses, cell
cycle, and DNA repair mechanisms, as well as during tachyzoite to bradyzoite stage
conversion (6, 15, 69).
Histones are small basic proteins that assemble in an octamer consisting of two
copies of histone proteins H2A, H2B, H3, and H4. These proteins combine with ~147 bp
of DNA wound around the octamer core to form the nucleosome. Nucleosomes are linked
together by stretches of unbound DNA called linker DNA. Post-translational
modifications (PTMs) of histones are important to regulate gene expression (57, 80).
PTMs of residues on histones, such as methylation and acetylation, increase or decrease
DNA binding, and recruit transcription factors all of which can promote gene expression
or gene silencing (68, 80). Acetylation of histone in T. gondii is associated with gene
activation (35). T. gondii also expresses unique variants of histones H3.3 and CenH3 of
H3, H2A.Z and H2A.X and H2B.Z variants of H2 (15). Histone PTMs are dynamic and
change with the conditions of the cell. The T. gondii genome encodes diverse chromatin
remodeling proteins including histone deacetylases, acetyltransferases, demethylases,
lysine and arginine methyltransferases, kinases, ubiquitin ligases, and small ubiquitin
related modifier (SUMO) conjugating enzymes (57, 70).Of all the histone modifying
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genes the three that are most studied include the histone acetyltransferases GCN5-A and
GCN5B and the histone deacetylase HDAC3 which are implicated in regulating
tachyzoite to bradyzoite transition. Attempts to delete GCN5B were lethal suggesting its
importance to parasite growth (39, 88). A catalytically inactive GCN5B expressed under
an inducible promoter revealed that parasites expressing inactive GCN5B could not
replicate. In addition, several transcription factors belonging to the APiAp2 family were
found to interact with GCN5B: Ap2IX-7, Ap2X-8, Ap2XI-2, and Ap2XII-4. HDAC3
activity prevents bradyzoite transition as chemical inhibition of it in vitro induced stage
switching (6, 70). In T. gondii histone acetylation is associated with gene activation.
Acetylation decreases the charge of histone proteins weakening their association with
DNA and opening the chromatin to allow binding by transcription factors and RNA
polymerase II. It is theorized that activating transcription factors recruit histone
acetyltransferases, while repressive factors recruit histone deacetylases or alternatively
compete with activating transcription factors for the same DNA motifs (Figure 8) (49,
88).
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Figure 8: Histone Modifications in T. gondii that Regulate Stage Differentiation
Chromatin remodeling is important for stage differentiation. Post-translational
modifications on histone tails either restrict access to DNA, or open chromatin for
binding of Ap2 transcription factors, Ap2 factors exist in competition with repressing
Ap2s preventing the binding of activating factors, activating Ap2s recruitment of RNA
polymerase II to transcribe mRNA.
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The ApiAp2 (A2P2) family of transcription factors are major regulators of the cell
cycle and bradyzoite transition in T. gondii. There are sixty-eight proteins with Ap2 DNA
binding domains in the parasite’s genome; twenty-four are cell cycle-related, eleven are
induced in bradyzoite conditions, twenty-seven are constitutively expressed, and six are
not expressed in tachyzoites (2, 3). Several Ap2 genes are induced during stress
conditions that lead to bradyzoite transition and are crucial both to activate and repress
bradyzoite associated genes (3, 42). Six Ap2s have been identified that contribute to the
regulation of tachyzoite to bradyzoite transitions; three are described as repressors of
bradyzoite genes, and three as activators of bradyzoite differentiation (Table 1).
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Table 1: Ap2 Transcription Factors Known to Regulate Bradyzoite Genes

Repressors of Bradyzoite Genes

Ap2IX-9(42), Ap2IV-4(42), Ap2IX-4(52)

Activators of Bradyzoite Genes

Ap2IV-3(42), Ap21b-1(42), Ap2XI-4(39)

The relationship between Ap2 transcription factors and bradyzoite differentiation is
complicated. Factors are annotated as activators or repressors based on experiments in
which the gene is either knocked out or conditionally expressed. The resulting impact of
their deletion, conditional expression or over-expression results in their definition as
either a “repressor” or “activator” of tachyzoite differentiation to bradyzoites. However,
in some cases the Ap2 transcription factor only impacts expression of a relatively small
subset of genes. Thus, a label as a “repressor” or “activator” does not fully capture the
relationship of each Ap2 transcription factor to stage differentiation. For example,
Ap2IX-9 increases in expression during transition even though it is a repressor of
bradyzoite associated genes.
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As mentioned above the relationships between the various Ap2 transcription
factors can be complicated as is their individual contribution to tachyzoite to bradyzoite
transitions. However, while many factors may turn off bradyzoite genes, paradoxically
they themselves are associated with bradyzoite transition. Two Ap2s, a repressor, Ap2IX9, and an activator Ap2IV-3 exist in a related expression pattern under cyst inducing
conditions (43, 50). Both factors bind to the promoter of the bradyzoite associated
antigen 1 (BAG1), considered to be the definitive marker of bradyzoites, with opposite
results on gene expression. However, Ap2IX-9 expression increases at 48 hours post
stress during which time parasites are well into transitioning to bradyzoites. After this
initial increase there is a subsequent decline that correlates to an increase in Ap2IV-3. All
of this indicates a complicated process of tachyzoite to bradyzoite transition. It is not a
binary state, but rather a multi-step process. The interaction of Ap2IX-9 prevents
premature commitment to bradyzoite development and expression of bradyzoite
associated genes too early in the transition process (42). Early bradyzoite development is
associated with four additional Ap2 genes Ap21b-1, Ap2VI-3, Ap2VIII-4 that in addition
to APXIX-9, and Ap2IV-3 are not expressed in tachyzoites. As tachyzoites differentiate
more completely into bradyzoites, Ap2IV-3 is upregulated. Thus, it could compete for
control of bradyzoite genes with Ap2IX-9. Eventually as bradyzoite mature Ap2XI-4
appears to replace Ap2IX-9 (42, 46, 52).
In addition to the current understanding of transition control by Ap2 transcription
factors, recent work has detailed a possible master regulator of bradyzoite transition (87).
While knocking out or overexpression of certain Ap2 transcription factors impacts
bradyzoite transition and cyst formation, these experiments have failed to completely
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inhibit these processes (47, 54). A Myb-like domain containing protein annotated as
BFD1 was found in a recent study to be critical for stage differentiation. Clones deleted
for BFD1 were completely incapable of forming cysts in induction conditions despite
normal growth in non-stressed conditions. BFD1 was found to bind to 652 sites in the
genome corresponding to 509 genes most of which were differentially regulated under
stressed conditions (87). The binding sites were near the transcriptional start sites of these
genes and conditional expression was sufficient to induce cyst formation absent of
normal induction conditions. Ap2 transcription factors can still be crucial to this process
as downstream mediators of bradyzoite transition, although further work must be done to
determine their precise relationship to this new regulator.
Twenty-four different Ap2s in T. gondii showed expression changes during
replication and may have a role in timing of gene expression over the course of the cell
cycle (3). A study of parasites arrested at the G1 phase of replication showed that Ap2X7, Ap2VIIa-6, Ap2XII-4, and Ap2VIII-4 were upregulated showing a potential role for
these factors in preventing the cell from entering S phase. Another factor Ap2XI-5 is
expressed throughout the cell cycle and was found to regulate virulence genes. Disruption
of this transcription factor led to an increase in virulence along with a reduction in
invasion (63).
Other than the presence of the Ap2 domain, Ap2 transcription factors have a low
degree of similarity. Ap2 domains are about sixty amino acids in size and consist of 3
beta-strands and one C-terminal alpha helix. Between the second and third strand is a
hairpin-like structure that is positively charged which enhances affinity to DNA (47, 62).
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Ap2 transcription factors bind to DNA motifs found in regulatory regions upstream of
gene promoters. DNA motifs have been discovered for several Ap2s in T. gondii (47, 54).

Immune Response to Infection
The host immune system can effectively control the acute infection. Since stress
is an important determiner of cyst induction, it has been proposed that the immune
response in the host is crucial to induce cysts in vivo (36). However, it appears that rather
than specific host immune factors triggering cyst formation, the effective suppression of
the acute infection by the immune system simply keeps the parasite’s attempts to
reinitiate acute infection in check. The reemergence of the infection in the
immunocompromised is due to the lack of suppression of tachyzoites, rather than the
withdrawal of an immune factor that causes the parasite to remain encysted (24). Cell
mediated immunity is critical for suppression of the parasite and survival of the host both
during acute and chronic infection as well as reactivation of infection. Increased
susceptibility of hosts to the parasite has been observed in patients with impaired T-cell
numbers and/or function and in mice that lack CD8+ and CD4+ T-cells (16, 24, 79). The
maintenance of CD8+ function is crucial during the chronic infection to control parasite
recrudescence. Highly virulent strains have evolved strategies to inhibit CD8+ T-cells
(16, 48). CD8+ function becomes compromised during infection by RH strain parasites.
Although RH parasites are capable of forming cysts the infection never progresses to the
chronic stage, as the host immune system is easily overwhelmed resulting in death (79,
93). The key cytokine needed to control T. gondii infection is IFN-γ, as mice deficient in
this cytokine succumb to infection by avirulent strains of T. gondii. Mice with chronic
infection that are administered IFN-γ antibodies develop reactivation of toxoplasmosis.
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IFN-γ stimulates the production of reactive oxygen species and nitric oxide (NO) in
macrophages, microglia, and astrocytes (34, 76, 77). Nitric oxide is they effector that
induces bradyzoite transition and cyst production, however it is not a necessary factor as
cyst formation occurs in inducible nitric oxide synthase deficient mice, as well as in mice
treated with aminoguanidine, an inhibitor of NO synthesis (9). Additionally, tumor
necrosis factor alpha (TNF-α) has also been shown to play a role in the establishment of
chronic infection. It may work synergistically with IFN-γ as treatment of infected
macrophages with these cytokines induced cyst formation (77, 96). Interleukin 6 (IL-6)
induces cyst formation in cultured human foreskin fibroblast cells, and IL-12 is important
to control both acute and chronic infection as it drives production of IFN-γ (31, 54, 72,
73).

FIKK
The Apicomplexa have a unique family of putative serine/threonine kinases
designated as FIKK for the conserved region of amino acids found in their kinase
domains consisting of a phenylalanine (F), isoleucine (I), and two lysines (K). This
family of kinases is unique and divergent from any other eukaryotic kinase family. While
almost universal in the Apicomplexa, with the exception of piroplasms, the number of
FIKK kinases differ between species with Plasmodium falciparum having 21 while both
Cryptosporidium parvum and Toxoplasma gondii having only one each. Most P.
falciparum FIKK kinases contain a PEXEL motif which designates the proteins for
export, these proteins are have known targets in the cytoskeleton of erythrocytes. The
closest homologues of TgFIKK are the C. parvum FIKK (CpFIKK), and FIKK 8 in
Plasmodium falciparum (PfFIKK8). A potential target of these two FIKK kinases
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consists of a short peptide sequence (RAPSFYR). This sequence is essentially a serine
residue flanked by two hydrophobic amino acids terminated with arginines in the +3 and
-3 positions. The study showed that modifying the terminal arginines substantially
reduced enzymatic activity (58).
The architecture of FIKK kinases include a highly variable N-terminal region
with a conserved C-terminus where the kinase domain with the eponymous amino acid
sequence is found (18, 19, 89). Most of the catalytically important residues of eukaryotic
protein kinases are conserved in FIKK proteins, except for the glycine triad.
Bioinformatic analysis of the T. gondii genome confirmed the presence of a single
FIKK kinase (TGME49_289050) in the parasite genome on chromosome IX (72). cDNA
sequencing and subsequent RNA sequencing data indicate that it is comprised of nine
exons interrupted by introns. Two isoforms were detected based on cDNA sequencing in
both Type I and Type II parasites. TgFIKK isoform I predominates in tachyzoites and
encodes an approximately 280 kDa protein encoded by 2762 amino acids. TgFIKK
isoform 2 is created by differential splicing that results in an in frame stop colon that
truncates the protein resulting in an incomplete catalytic domain. The FIKK kinase
transcript appears to be expressed in all strains of T. gondii examined to date. The
localization of the predominant TgFIKK Isoform 1 full length FIKK kinase in T. gondii
was investigated in our labe previously by creating a RH parasite with an endogenous
tagged FIKK kinase that expressed the florescent YFP protein on its 3’ end (72). The
FIKK-YFP endogenous tag was used to visualize the FIKK-YFP protein by
immunofluorescence during the parasite’s lytic cycle in vitro in tissue culture. HFF cells
infected with FIKK-YFP containing parasites were examined by immunofluorescence
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using a Zeiss inverted Axiovert 200 System. We were unable to visualize the FIKK-YFP
protein using the endogenous florescence of the YFP protein as the protein was not
sufficiently abundant. Thus we used a mouse monoclonal antibody cocktail to GFP
followed by a secondary Alexa 488-conjugated goat anti-mouse antibody to amplify the
FIKK-YFP signal (Figure 9).
These studies showed that the protein localized to the basal end of the parasite. In
independent studies MJ Gubbles at Boston College created a TY-tagged FIKK protein.
His group showed that FIKK-Ty co-localized with membrane occupation and recognition
nexus protein (MORN-1) a component of the parasite organelle called the basal complex.
He showed that the FIKK-Ty protein colocalizes with MORN1 inside the basal complex.
Furthermore, that FIKK-Ty sits apical to inner membrane complex 5 (IMC5) and apical
to the posterior cup marker Centrin 2. Thus, the FIKK kinase is toward the apical end of
the basal complex rather in the basal end that would be closer to a putative gap in the
parasite membrane cytoskeleton that has been hypothesized to function as a posterior
pore in the parasite. While FIKK colocalization with MORN1 occurred in the mother
cells, the FIKK kinase was restricted to the mature parasites and was not found in
developing daughter cells (Figure 9).The FIKK kinase is the only parasite protein
published to date that is found in association only with the mother’s basal complex and
not the daughters’. Proteomic analysis of the parasite basal complex using MORN1
revealed that MORN1 and FIKK are associated with one another and not just proximal to
one another in the basal complex (40). The FIKK kinase localization with the basal
complex suggested that the protein may be important for parasite replication via
endodyogeny (Figure 4). However the work in our lab indicated that deletion of the FIKK
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gene from the genome of RH parasites had no effect on parasite replication in vitro in
HFF cells (72).
These previous studies in our laboratory only indicate that the FIKK kinase is not
essential for the parasite lytic cycle in vitro in RH strain parasites. While this is an
important finding, the function of the TgFIKK kinase remains unknown as does its
potential contribution to pathogenesis. Furthermore, the Type I strain RH is not
representative of the infections typically found in humans nor is it able to complete the
parasite life cycle in terms of its sexual cycle in feline hosts or its cyst cycle in secondary
hosts including humans. Kinases have clearly been implicated in tachyzoite to bradyzoite
differentiation and cyst formation (77). Thus, in the current study we evaluated the
contribution of the FIKK kinase in stage differentiation and cyst formation. To more
readily address the role of the FIKK kinase in stage differentiation and cyst formation, we
deleted the entire FIKK kinase gene in the Type II Prugnaud strain of the parasite. We
also complemented the FIKK gene deletion in trans using the FIKK kinase using its
endogenous promoter and full-length genomic region of TgFIKK Isoform1. We show that
the FIKK kinase contributes to acute infection by the Type II Prugnaud strain in mice
even though it does not significantly contribute to the parasite lytic cycle in vitro.
Furthermore, we show that the FIKK kinase is important for the parasite’s ability to form
cysts in vitro or chronic infection in vivo. Although its mechanism of action remains
unknown, our data suggest that the FIKK kinase plays a critical role in the ability of the
parasite to enter the bradyzoite differentiation pathway in order for the parasite to
differentiate to bradyzoites and to form tissue cysts to establish chronic infection.
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Figure 9: Localization of Tagged FIKK Proteins
Part A: Human foreskin fibroblast cells were infected with parasites over the course of 36
hours. Images were taken at 100x. The localization of FIKK YFP in immunofluorescence
with the signal enhanced by an anti-GFP antibody with the parasite labeled with an antitoxoplasma antibody (red) Images were taken on Zeiss inverted Axiovert 200 System
Part B. Colocalization of the Ty-FIKK and Cherry-MORN1 (72).
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Chronic infection in vivo
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Materials and Methods
HFF Cell Culture
Human foreskin fibroblast cells were obtained from the American Type Culture
Collection (ATCC, SCRC1041). HFF cells were passaged in tissue culture flasks (T25,
T75, and T150s.) Cells were grown in T150s and allowed to come to confluency. Cells
were passed into new flasks at least every four weeks. Confluent T150 flasks of HFF
cells were split by a two-minute incubation with trypsin (Gibco) at 37°C until cells lifted
off of the bottom of the flask. Trypsin was inhibited by adding 5mL of D10 [DMEM
(Gibco) high glucose supplemented with 10% FBS (Gibco) and L-glutamine, to inhibit
the trypsin enzyme. The cells were centrifuged at 270 x g for 5 minutes to pellet the cells.
For seeding T150s, the cell pellet was resuspended in D10 and the cell suspension
divided between six new T150 flasks. For seeding T25 flasks the cell pellet was
resuspended in 50mL of D10 and the cell suspension divided between ten T25 flasks. All
flasks of HFF cells were kept in a 37°C incubator with ambient air plus 5% CO2.

Parasite Culture/Clones
Parasites were grown in T25 flasks with a confluent monolayer of HFF cells by
transfer of 1mL of parasites from a lysed out T25 cell culture into a new T25 flask with
confluent HFF cells every two days. Four T. gondii parental strains/clones were used for
genetic manipulations. The Type I genotype strain RH with both Ku80 and HPT deleted
(RHΔKu80ΔHPT) was used to create the YFP-tagged FIKK for the FIKK localization
studies. The T. gondii Type II genotype Prugnaud (Pru) with either both Ku80 and HPT
deleted (ME49 lineage; PruΔKu80ΔHPT) or only HPT deleted (PruΔHPT) were used to
create gene deletions for the FIKK gene. Additionally, a second line of PruΔHPT was
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clonally purified (PruΔHPT WT2) (Figure 10). The PruΔKu80ΔFIKK clone was used to
create the FIKK complement clones (Table 2).
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Table 2: Parasite Strains and Genetically Modified Parasite Clones Used in the Thesis
Background

Parental Strain

Created Clones

RH (Type 1 genotype). Acute

RH-FIKK-YFP

Strain
RHΔKu80ΔHPT

infection and tachyzoites in vitro
PruΔKu80ΔHPT

PruΔHPT

PruΔKu80 (Type 2 genotype).

PruΔKu80ΔFIKK

Acute and chronic infection and in

PruΔKu80ΔFIKK+FIKK1

vitro studies including cyst

PruΔKu80ΔFIKK+FIKK2

formation

PruΔKu80ΔFIKK+FIKK3

PruΔHPT WT1

PruΔHPTΔFIKK 1, 2

PruΔHPT WT2

PruΔHPTΔFIKK 3, 4
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Figure 10: Creation of the Clonal Pru∆HPT Wild Type (WT) 2 Clone
Pru∆HPT WT2 was created by cloning WT1 by single cell cloning in 96 well plates with
confluent HFF cells. The first plate was replica plated and parasites were stressed using
sodium nitroprusside to induce cyst formation. Parasites were stained using FITCconjugated DBA and cystogenic isolates were identified. A number of these clones were
selected from the replicate plate in culture. One was randomly chosen and labeled
PruΔHPT WT2 and used to create a PruΔHPTΔFIKK clone.
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Parasite Genetic Manipulation
Electroporation Protocol
Plasmids were grown in bacterial culture by transfecting Oneshot Top10
chemically competent Escherichia coli (E. coli) (Thermo Fischer) and grown in
Lysogeny broth (LB) supplemented with 100 micrograms per milliliter of carbenicillin to
select for the plasmids. The plasmids were purified using the Qiagen Plasmid Midi Kit
and prepared for electroporation by mixing with Cytomix (120 mM KCl, 0.15 mM CaCl2
10 mM K2HPO4/KH2PO4 pH 7.6, 25 mM HEPES pH 7.6, 2 mM EGTA, 5 mM MgCl2).
Parasites from two lysed T25s were centrifuged at 1200 RPM for 10 minutes and washed
twice with cytomix. Plasmids were suspended in 400 microliters of cytomix and mixed
with parasites. The mixture was placed into a 2mm cuvette and pulsed at 1.5Kv,
resistance 25Ω, capacitor setting of 25Uf using B7 X ECM 630. After
electrotransformation, the parasites were placed under selection in HFF cells.

Creation of the FIKK-YFP Clone
The T. gondii FIKK in the RH∆Ku80 strain was endogenously tagged at the 3’
end with a yellow fluorescent protein tag. A FIKK-YFP fusion transcript was created by
amplifying a 1.5KB fragment of FIKK without the stop codon and inserted into a PacI
digested VC-YFP plasmid (Figure 11) using ligation independent cloning to fuse the
FIKK fragment in frame with YFP. The resulting FIKK-YFP plasmid construct was
linearized with BsiWI and electroporated into wild-type RH∆Ku80 parasites and selected
using 50ug/mL of mycophenolic acid with 25ug/mL of xanthine in D10 medium. After
selection parasites were single cell cloned in HFF cells using 96 well plates to isolate
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single parasite isolates. Positively tagged isolates were identified by amplifying a region
of the genome containing the FIKK-YFP fusion by PCR.
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Figure 11: VC YFP Plasmid Including the Cloned FIKK Sequence
The YFP-FIKK plasmid used for endogenous tagging of the 3’end of the FIKK gene with
yellow florescent protein (YFP). VC YFP plasmid with the final 1500 base pairs
homologous to the 3’ end of the FIKK gene (and the stop codon removed) cloned
immediately upstream of the YFP tag.
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Creation of FIKK Gene Deleted Parasite Clones
Wild-type Pru∆HPT and Pru∆Ku80 strains were used to create FIKK gene
deletion clones. The FIKK gene deletion targeting construct (Figure 12) was created by
PCR amplification of 2176 bps of the T. gondii genome sequence 313 bps upstream of
the FIKK predicted start site using Phusion High-Fidelity PCR Master Mix with HF. The
amplified product was validated and cloned upstream of the HPT gene in the T. gondii
plasmid HPT mini. A 2142 bp T. gondii genomic sequence 126 bp downstream of the
FIKK gene 3’ poly A sequence was PCR amplified, validated, and cloned into the FIKK
targeting plasmid downstream of the HPT gene. The completed FIKK targeting plasmid
was named “pmini stko2”. The targeting plasmid was linearized using the NotI restriction
enzyme and 60ug of plasmid was electroporated into wild-type strains. Selection was
performed for 5-7 days using 50ug/mL of mycophenolic acid with 25ug/mL of xanthine
in D10 in confluent HFF cells in T150 flasks. After selection a population PCR was
performed for the presence of the HPT gene, if positive the population was single cell
cloned in 96 well plates to isolate single parasites based on plaque formation. After
isolation parasites were cloned into 24 well plates and DNA was purified using the
Qiagen DNeasy Blood and Tissue Kit as per the kit instructions. Junctional PCR was
used to identify parasite clones that had inserted the HPT gene in place of the FIKK
genetic locus. Junctional PCR used two sets of primers. One primer set was designed to
amplify the junctional region 5’ upstream of the FIKK gene targeting plasmid and the 5’
end of the HPT gene. The other primer set was designed to amplify the junctional region
in the 3’ end of the HPT gene and the 3’ end of the T. gondii genome downstream of the
FIKK gene targeting plasmid (Table 3). The amplified ~3KB regions thus included a
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section of the HPT gene, the region of the genome used to insure efficient recombination
and an area of the genome immediately outside of this area. This ensures that the HPT
gene inserted into and replaced the entire FIKK gene (Figure 13). Gene deletion of the
FIKK gene was confirmed by isolation of RNA using the RNAeasy plus kit (Qiagen),
removal of residual DNA using the Turbo DNAse kit (ThermoFisher), and synthesis of
cDNA using the SuperScript First-Strand Synthesis System (Invitrogen) (Figure 14,
Table 5).
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Figure 12: ∆FIKK Plasmid
A schematic of the Pmini stko2 plasmid used to delete the entire FIKK gene. The plasmid
includes the HPT gene flanked 5’ with approximately 2KB upstream of the 5’ FIKK gene
locus, and 3’ with approximately 2 KB downstream of the FIKK gene locus. The plasmid
is designed to promote homologous recombination in the FIKK gene locus and replace
entire endogenous FIKK gene with HPT.
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Table 3: Primers Used to Confirm FIKK Knockout
FIKK external forward in sequence

tgatgctaggctcctcttagt

HPT in sequence forward

GGCGTATGACATCCACAGAA

HPT Rev Primer in sequence

GAGCCTTTCAGGATGCAAATG

FIKK external rev in sequence

cggagacaccctcaagtataatg

Primers Used in Junctional PCR to confirm FIKK deletion.
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Creation of Additional FIKK Gene Deletions From a Newly Cloned Pru
Parental Line.
Initial attempts to complement the PruΔHPTΔFIKK were unsuccessful. In lieu of
complementation a second set of FIKK deletion clones was created as an alternative
method of confirming any potential phenotype associated with deletion of the FIKK
gene. There was concern that genetic drift over time may have introduced variation in the
population of Pru∆HPT parasites used in the lab. To eliminate any potential
complications due to genetic drift a clonal line of Pru∆HPT was created. This line was
then used to make a second set of ∆FIKK clones. First, the parental parasites were single
cell cloned into 96 well plates containing confluent monolayers of HFF cells. After 7
days the plates were checked to identify wells that contained only a single plaque
indicating the presence of a single parasite clone within the well. Single clones of the
parasite were used to create two replicate 96-well plates containing confluent HFF cells.
After three days of culture of one plate in the presence of sodium nitroprusside (SNP)
wells were fixed with 4% paraformaldehyde, permeabilized and stained with FITCconjugated Dolichos biflorus (DBA) lectin. Each well of the 96 well plates were screened
for cyst formation (DBA positive vacuoles) by fluorescent microscopy with a 20X
objective. Most parasite clones appeared similar in terms of their ability to form cysts in
the presence of SNP. A robust cyst forming parasite clone was used to create the second
set of FIKK gene deletion parasites.
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Pru∆HPT∆FIKK

Pru∆Ku80∆FIKK

Figure 13: Junctional PCR of ∆FIKK Clones
The deletion of the FIKK kinase was confirmed using junctional PCR with positive
junctional PCR bands indicating the replacement of the FIKK gene with HPT.
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Figure 14: QPCR of ∆FIKK Clones and Complements
Quantitative real time reverse transcriptase PCR was performed on the wild-type
(Pru∆HPT, Pru∆Ku80) and ∆FIKK clones to confirm deletion of the FIKK gene. After
complementation it was used to confirm the expression of the FIKK gene in the
complemented clones.
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Creation of PruΔKu80 FIKK Complemented Clones
Deletion of the FIKK kinase was performed in the original Pru∆HPT line, the
single cell clone Pru∆HPT line, and in a Pru∆Ku80 line. Attempts at complementation in
the Pru∆HPT∆FIKK clones were unsuccessful. This was not surprising due to the
presence of the robust non-homologous end joining repair system in T. gondii. Also, HPT
is one of only a few efficient selectable markers for gene deletion in T. gondii and its use
for complementation was precluded as it had been used for the creation of the FIKK gene
deleted clone. Also the plasmid used for complementation included both the entire FIKK
gene, plus 2 kb homologous regions on either side of the gene resulting in a large plasmid
(24163 bp) that may have further complicated attempts to complementation (Figure 15).
To overcome the NHEJ repair system the Pru∆Ku80∆FIKK clone was used as the
parental line was missing the ku80 gene which renders the NHEJ repair pathway nonfunctional. Additionally, to overcome the lower transformation efficiency of large
plasmids the complementation construct was not digested as supercoiled plasmids have a
higher efficiency in terms of uptake. Complementation was done in trans in the UPRT
locus with positive selection using 5-floxuridine. Current trans complementation
protocols for T. gondii recommend using 5um 5-FUDR for positive selection, the lower
dose recommended to counterbalance any toxic effect on the host cells needed to grow
the parasites. However, repeated attempts at genetic complementation were unsuccessful
using standard protocols even in the Pru∆Ku80∆FIKK clone. 5-FUDR targets actively
replicating cells by incorporating into growing DNA strands during the S phase of the
cell cycle, hence its application as a chemotherapy drug and immunosuppressant agent.
HFF cells are a primary cell line and exhibit contact inhibition and thus when they are
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confluent become quiescent. It was theorized that a higher concentration of 5-FUDR
could be used to select for transformants to help compensate for a potentially low rate of
recombination. To determine the highest concentration of 5-FUDR that can be tolerated
by the HFF cells a 24 well plate was seeded with cells and allowed to become confluent.
The medium in the wells was aspirated and replaced with D10 containing varying
concentrations of 5-FUDR ranging from 5um to 100um by 5um steps and incubated for
one week and checked every day for signs of cell death (rounding, lifting off, and the
accumulation of dead cell debris in the culture). After one week no well showed any
signs of cell pathology. Based on these results 100um 5-FUDR was used for selection.
The uncut complementation plasmid (Figure 15) was used for electroporation.
After electroporation the parasites were inoculated into a single T150 containing
confluent HFF cells and left to invade for 24 hours at 37°C then DMEM containing
100um of FUDR was added and selection was performed for 5-7 days. After selection
parasites were subcloned into five 6-well plates and grown under further selection until
lysis of the HFF cell monolayer. Parasite populations were transferred to new wells
containing HFF cells, and remaining parasites not used for passage were used to isolate
DNA for PCR to detect the presence of the FIKK gene in each parasite population.
Parasites from positive wells were single cell cloned into 96 well plates and grown for 5
days. Parasites from wells with single plaques were subcloned into 24 well plates and
grown until lysis of the HFF monolayer. After lysis, single parasite clones were evaluated
by junctional PCR to identify the presence of the FIKK gene within the UPRT locus.
Three parasite clones out three 24 well plates were isolated that were positive by PCR for
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the FIKK gene and the junctional 5’ and 3’ PCRs. These isolates were confirmed by
quantitative reverse transcriptase PCR using primers to the FIKK mRNA (Figure 14).
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Figure 15: FIKK Complement Plasmid with BirA Tag
The plasmid used for complementation of the ΔFIKK clones with the full length genomic
FIKK gene and its endogenous promoter and 3’ untranslated region (UTR). The FIKK
complement contains a BirA tag for proximal biotinylation labeling and a HA tag.
Flanking regions 5’ and 3’ of the FIKK gene locus contain approximately 2 KB regions
homologous to the T. gondii UPT locus to target the transgene to the UPT locus to enable
selection by 5-floxuridine (FUDR).
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Live Cell Imaging
Live cell imaging of the RH∆Ku80 with FIKK-YFP was performed on a Nikon
TiE inverted fluorescent microscope. For live cell imaging of parasites, HFF cells were
grown to confluence overnight in D10 phenol red-free media on Eppendorf cell imaging
chambers with a glass coverslip bottom. The chambers were placed in a 37°C chamber
with 5% CO2 that was mounted on the stage of the Nikon Eclipse TiE system. The
confluent HFF cells were challenged with RH FIKK-YFP parasites. A Nikon CFI Plan
Apo100x objective (1.45/0.13mm oil) was used for live-cell imaging. Images of multiple
parasites/chambers were taken every twenty minutes over a thirty-six-hour timespan.

Bradyzoite-Inducing Conditions and Cyst Formation In vitro
HFF cells were grown to confluency in either 8 well chamber slides, or 24 well
plates (Eppendorf). 50,000 parasites were inoculated, and different stress conditions were
used to induce cyst formation (Figure 16).
1. Nitric Oxide Stress: Sodium nitroprusside was dissolved to a concentration of
115uM in D10 DMEM. The SNP supplemented medium was replaced every day.
2. Arginine Starvation Stress: Stable isotope labeling with amino acids in cell
culture (SILAC) medium without arginine and lysine was supplemented with
lysine HCl to 0.146g/l to make Arg- medium supplemented with 1% FBS. The
D10 used to grow the HFF cells was replaced with Arg- medium for 24 hours
before parasite infection.
3. Drug Treatment Stress: Parasites were incubated in D10 supplemented with
50ug/mL of mycophenolic acid extracellularly without CO2 for four hours before
infection in cells in D10 medium with 10% FBS.
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4. Alkaline Stress: D10 supplemented with 10uM of HEPES was adjusted to a pH of
8 with sodium hydroxide. The parasites were incubated for 3 days in alkaline
medium.
5. Non-stress: Parasites were used to infect HFF cells and cultured in normal D10.

Immunofluorescence Staining Procedure
Plates with HFF cells infected with parasites were fixed for 20 minutes in 4%
paraformaldehyde in PBS then rinsed with PBS to remove residual fixative. Cells were
permeabilized using 0.2% Triton X-100 in PBS for 5 minutes at room temperature and
rinsed with PBS. Plates were then blocked in 10% FBS in PBS for 30 minutes at room
temperature. Primary antibodies were used at a dilution range of 1:1000 to 1:500 in
blocking solution and plates were stained for 1 hour at room temperature or at 4°C
overnight. Plates were rinsed with 0.05% Tween 20 in PBS three times and then with
PBS once. Fluorochrome-conjugated secondary antibodies were used at a dilution of
1:200 to 1:100 in PBS and left on plates for 1 hour at room temperature. Plates were
rinsed three times with 0.05% Tween 20 in PBS and once with PBS. Then plates were
stained with 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) (ThermoFischer)
diluted to 300nM in PBS for 5 minutes at room temperature to stain the parasite and host
cell nuclei. Plates were washed once with PBS and then 500ul of PBS was left on plates
to prevent cells from drying. Plates were examined immediately or kept at 4°C for up to a
week before examination on the microscope. Determination of cyst formation was done
using the Nikon Tie series inverted fluorescent microscope by counting cysts at 40X
magnification.
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Table 4: Clones Used for in vitro and in vivo Studies of Acute and Chronic Infection
PruΔKu80ΔHPT PruΔKu80 (Type 2:

PruΔKu80ΔFIKK

acute and chronic

PruΔKu80ΔFIKK+FIKK1

infection)

PruΔKu80ΔFIKK+FIKK2
PruΔKu80ΔFIKK+FIKK3

PruΔHPT

PruΔHPT WT1

PruΔHPTΔFIKK 1, 2

PruΔHPT WT2

PruΔHPTΔFIKK 3, 4
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Figure 16: Cyst Induction Conditions
Top panel: A schematic showing the different exogenous inducers of bradyzoitedifferentiation that were analyzed to compare cyst production by wild type, ΔFIKK
clones, and FIKK complement clones. Bottom panel: The picture shows a fluorescent
image superimposed with differential interference contrast (DIC) of parasite vacuoles
within an HFF monolayer. Parasites were stained with a polyclonal mouse anti-T. gondii
antibody followed by an Alexa 594 goat anti-mouse secondary antibody (red) and FITCconjugated Dolichos biflorus Agglutinin (DBA) (green). The number of cysts compared
to the number of total PVs was determined to quantify percent cysts/PV. The picture was
taken with a Nikon Eclipse Tie Florescent microscope using a 100X oil objective.
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After infection parasites were grown for three days at 37°C after which they were
fixed in 4% paraformaldehyde for 20 minutes at room temperature. They were then
permeabilized for 5 minutes in 0.2% TritonX-100 at room temperature and blocked with
10% FBS for 30 minutes. A polyclonal anti-toxoplasma antibody from mouse serum was
used to label the parasites with secondary staining using a goat-anti mouse antibody
conjugated to Alexa-594 (Jackson). Cysts were stained using a FITC-conjugated DBA
lectin. Four counts of 100 parasitophorous vacuoles were evaluated in the red channel,
with cyst counts evaluated in the green channel. The number of cysts as a percentage of
total PVs was calculated. A student’s T-test was used to compare the numbers between
clones.

Cyst Formation in vivo
To measure in vivo infection, cyst burdens were calculated in the chronic
infection in two strains of mice CD-1 and BALB/c. For CD-1 mice infection two
experiments were performed using the two sets of Pru∆HPT wild-type parasites and their
respective FIKK gene deletions. In BALB/C mice the Pru∆Ku80, ∆FIKK, and FIKK
complements were used for infection. Mice were infected intraperitoneally with parasites.
After 30 days post-infection the mice were anesthetized using isoflurane and euthanized
by cervical dislocation. Brains were then removed and mixed with 1mL of PBS. The
brains were homogenized with a mortar and pestle to make a brain suspension (Figure
17). The suspension was fixed for 30 minutes in 2.5% paraformaldehyde in PBS. After
fixation 100uL of the brain homogenates were stained using a 1:200 dilution of FITCconjugated DBA to stain cysts. A wet mount on slides was created for three independent
5uL smears of the brain and cysts were counted in each wet mount. Total cyst burden in a
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brain was calculated by multiplying by the dilution factor (10 due to the 100uL volume
taken from the 1mL brain homogenate).
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Figure 17: Procedure for Investigating Chronic Infection in vivo
Mice were infected intraperitoneally with parasites. Animals were maintained for 30 days
post-infection at which point they were euthanized, brains were extracted, and wet
mounts made with cyst stained using FITC-DBA. Counts were performed on Nikon Tie
inverted fluorescent microscope at 40X magnification.
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Acute Infection in vivo
Acute infection was evaluated using the Pru∆Ku80 and the clones derived from it
(Table 4). C56BL6 mice were infected with parasites and observed twice daily for seven
days post-infection and then once a day for an additional seven days. Mice were observed
to evaluate the onset of symptoms that included ruffled fur. Any mice that appeared
moribund showing lack of movement, shacking, and cold temperature were anesthetized
with isoflurane and euthanized by cervical dislocation.
For all mouse studies parasites were taken from lysed T25 flasks, parasites were
counted using hemocytometer and the appropriate number of parasites needed were
calculated. To ensure the proper number of parasites were injected, plaque assays were
used by inoculating the parasites from the diluted volume onto 24 well plates with
confluent HFF cells and counting plaque numbers between the volumes used to infect the
mice.

Plaque Assay in vitro for Stressed Versus Unstressed Parasites.
Two 24 well plates were seeded with HFF cells and allowed to become confluent.
Parasites were taken from a lysed T25 and divided into two groups. One group of
parasites was centrifuged for 10 minutes at 1300 RPM and the parasite pellet resuspended
in D10 pH 8 supplemented with 50 micrograms of mycophenolic acid. These conditions
stress the parasites by starving them of pyrimidines, this was done in order to induce
stage differentiation. These parasites were incubated at 37°C for 4 hours extracellular in
order to stress the parasites. The other group of parasites were resuspended in D10 pH 7
and immediately allowed to invade HFF cells (non-stressed parasites). Fifty parasites
from stressed or non-stressed groups were inoculated per well in a 24 well plate
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containing confluent HFF cells and incubated at 37°C for 5-7 days to allow plaques to
form. The plates were then fixed with 100% ethanol for 5 minutes and stained with a
solution of 0.05% w/v of crystal in violet in a solution of 20% ethanol in PBS for 5
minutes. Images of wells were taken on using an inverted Nikon Eclipse Tie fluorescent
microscope at 10X magnification. Plaque sizes were measured using the FIJI image
analysis software (Figure 18)
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Figure 18: Plaque Assay
Parasites were taken from lysed T25s and divided into two groups. One group was
stressed for 4 hours in alkaline medium at pH of 8 supplemented with 50 micrograms of
MPA/mL for 4 hours to stress parasites and induce bradyzoite transition. Parasites were
inoculated onto 24 well plates with confluent HFF cells at 50 parasites per well and
incubated for 5-7 days. After plaques formed plates were fixed and stained with crystal
violet and images were taken at 10X on the Nikon Tie Inverted Fluorescent microscope
in brightfield. Plaque area was measured by taking the area of plaques.
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Invasion Assay
Parasite invasion was measured using differential permeabilization to detect
extracellular versus intracellular parasites (in versus out assay). The invasion assay was
performed using confluent 24 well plates of HFF cells. Medium from the cells was
aspirated, 500uL of medium from lysed T25 flasks containing 10^6 parasites was added
and the plates were incubated for 10 minutes at room temperature. After inoculation, PBS
warmed to 37°C was placed in the reservoir around the wells, and the plates were placed
in a 37°C incubator for 30 minutes to induce parasite invasion of the HFF cells. After the
30 minutes incubation the plates were washed with PBS, fixed with 4%
paraformaldehyde for 20 minutes, and blocked with 10% FBS for 30 minutes. The
extracellular parasites were stained with a polyclonal anti-toxoplasma rabbit antibody.
Plates were then washed three times with PBS. plates were incubated with a FITCconjugated anti-rabbit secondary for one hour at room temperature, and again were
washed three times with PBS. The cells were permeabilized for 5 minutes with 0.2%
Triton X-100 in PBS for 5 minutes, washed again, and then blocked a second time with
10% FBS for 30 minutes. Intracellular parasites were labeled with a mouse polyclonal
anti-toxoplasma antibody for one hour at room temperature, washed 3x with PBS and
then incubated with Alex-fluor 647 conjugated anti-mouse secondary antibody for one
hour at room temperature (Figure 19). The plates were washed three times with PBS and
parasites were counted on the Nikon TiE inverted fluorescent microscope. Four counts of
100 parasites were taken, invasion was quantified by calculating the percent of parasites
that invaded out of the total parasites.
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Figure 19: Invasion Assay
Parasites were taken from lysed T25s and inoculated onto 24 well plates with confluent
HFF cells for 10 minutes at room temperature. Warm PBS at 37°C was then added to the
reservoir around the wells and the plates were placed in a 37°C incubator to induce
invasion. After incubation plates were fixed and stained to label extracellular parasites,
then permeabilized and stained to label internalized parasites.
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Replication Assay
Intracellular parasite replication was quantified by measuring the parasites per
vacuole over time. 24 well plates with confluent HFF cells were inoculated with 50,000
parasites. Two sets of plates were used, stressed and non-stressed. Stressed plates were
inoculated with parasites stressed for four hours in MPA/pH 8 D10 medium. At 24, 48,
and 72 hours plates were fixed with 4% paraformaldehyde for 20 minutes, permeabilized
with 0.2% triton X 100 for 5 minutes, and stained for one hour with a mouse-polyclonal
anti-toxoplasma antibody and then washed three times with PBS. Plates were then stained
with a secondary antibody, Alexa Fluor 595 conjugated goat anti-mouse for 1 hour,
rinsed again and counterstained with DAPI. At each time point in each condition, 100
vacuoles were counted and the total parasites per vacuole were counted. Data was binned
into four categories based on parasites per vacuole: 1-2, 3-6, 6-10, 10 and more.
Replication was quantified by calculating the percent of vacuoles out of the total within
each bin for each time point.

qRT-PCRs
Quantitative reverse-transcriptase polymerase chain reaction was used to confirm
FIKK deletion, and complementation. Also, to determine gene expression in response to
cyst inducing conditions. qRT-PCR was performed using an Applied Biosystems
Quantstudio 5 thermocycler using primers against various genes in the Toxoplasma
gondii genome using the NCBI primer design tool and checked against both the T. gondii
and human genomes. qRT-PCRs were performed using the Applied Biosystems Fast
SYBR Green Master Mix. Expression change was determined by the ∆∆Ct method and
normalizing to the parasite’s housekeeping gene tubulin (Tub1) (Table 5).
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Table 5: Primers Used for qRT-PCRs
Bradyzoite
Markers
Housekeeping Gene

BAG1QF

GGAGCCATCGTTATCAAAGGAGA

Tub1QF

ATCAGCAGTACCAGGACGCC

BAG1QR

CGGACACTCGCTCAGTCAAA

Tub1QR

GAGAAAAGCCACTACGCGCC

ENO1QF

GCGAGATTTTGGATTCTCGCGG

ENO1QR

CGCCTTTCCCCAAGTACCGT

LDH2QF

GTAACAGGCATGCCAGAAGGG

FIKK
FIKKqf

ACTTCCTGATCGAGGTTCCCA LDH2QR

GACATCCGATCCGGCGATCT

FIKKqr

GGACTTGGACGACCGTTTGA

CST1QF

ACCTCCGGTCCAAGAAACCG

CST1QR

GCGGGTCGACTTTGGGAAAC

BPK1QF

CGCATTCCCCTTGCAGATATGA

BPK1QR

CACTAACTCTCTGGCGGGCA

MCP4QF

CGGATGATTGGGCGTGCTTT

MCP4QR

TGAATGAAGTTGCTCTGGCACG

Ap2 Transcription Factors
Ap2XII-VIf

CTGGCCCCTAGGCAAGAGTT

Ap2XII-VIr

GCCTAGCTCAGAAACCAGTTCG

Ap2XI-IVf

GGAGCCACCCCCATGATGAA

Ap2XI-IVr

CCGAGCAAAGTCGTCGAGTG

Ap2IX-IXf

TGCGCGCCAAAAGGAAAATATC

Ap2IX-IXr

TGCGTCCTGCAAGAGAGATATTTT

Ap2IX-IVf

TCTACGAGGCCGATTGCAGG

Ap2IX-IVr

AGGAGGCGTCGTCATAACCG

Ap2IV-IIIf

ACACAGGGCAGTCGTTTCCA

Ap2IV-IIIr

ATGGCTTGGCGCGAGTATCT

Ap2IV-IVf

GATGCGCTTCCGACGTCAAG

Ap2IV-IVr

CGACTGGCGATTGGCTGTTC

69

RNA Sequencing
The parasite genome is approximately 66 MB and encodes approximately 8920
genes. The expectation was that purified parasite RNA would contain approximately 10
percent HFF cell contamination. These values were used to determine RNA sequencing
depth including the number of lanes and barcoding and multiplexing of samples.
Samples from Pru∆HPT and Pru∆HPT∆FIKK 3 were prepared and sent off for
RNA sequencing by Cornell University’s Genomics Core. The samples were prepared
under SNP stress with three-time points 24, 48, and 72 hours. Three biological samples
were used for group. Additionally, a non-stressed extracellular time point was taken at 24
hours which was labeled as T0. Parasites were grown in HFF cells and then they were
liberated from the host cells by passage through a 25-gauge needle. Subsequent passages
through a 27-gauge needle ensure lysis of parasites. Fresh D10 media was added to wash
parasites and remove HFF cell debris and parasites were pelleted by centrifugation.
Parasites were also passed through a 3um nucleopore filter to further purify parasites.
RNA was isolated from parasites using the Qiagen RNAesy Plus Kit. RNA was further
treated with TURBO DNA-free removal kit (Thermo Fisher) to ensure removal of any
contaminating DNA. The parasites were pelleted and sent to Cornell on dry ice. RNA
quality was validated using the Agilent 2100 Bioanalyzer. RNA sequencing (polyAselected, paired read, barcoded and multiplexed using 3 lanes) was performed using an
Illumina HiSeq 2000 sequencer. Parasite sequences were aligned using STAR to the
Toxoplasma gondii ME49 reference genome from ToxoDB (https://toxodb.org/toxo).
Uniquely mapped sequences were intersected with composite gene models from
ToxoDB.org (32). Composite gene models for each gene consisted of the union of exons
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of all transcript isoforms of that gene. Uniquely mapped reads that unambiguously
overlapped with no more than one composite gene model were counted for that gene
model.; the remaining reads were discarded. The counts for each gene model correspond
to gene expression values and were used for gene expression analysis. Preliminary
exploration of the data was achieved via simple error ratio estimates, principle
component analysis, and multidimensional scaling. Differential gene expression was
performed with default normalization strategies using limma, edgeR and DeqSeq2. Only
genes with adjusted p-values less than 0.5 were considered differentially expressed.
Log2fold change and p-values were also calculated using the Benjamini-Hochberg
method.

Proteomics and Phosphoproteomics
Parasite groups and biological replicates for RNAseq and proteomics are shown
in Table 6. For proteomic analysis of both Pru∆HPT and Pru∆HPT∆FIKK3 parasites in
HFF cells were grown for 72 hours under SNP stress and for 24 hours without stress
(T0). At these time points parasites were intracellular. Parasites could not be purified
from HFF cells without losing the proteins in the PV and PVM as well as in nascent
cysts. Thus, the predominant proteins were from HFF cells rather than parasites. A high
multiplicity of infection was used to maximize the ratio of parasites to HFF cells.
However, this also resulted in overall poor differentiation of parasites to cysts. Parasites
were pelleted and shipped to the Proteomics and Mass Spectrometry Facility at the
Donald Danforth Plant Science Center, St. Louis, MO. Ribosomal proteins in parasites
versus HFF cells are different sizes and based on their expression following horizontal
gel electrophoresis the estimate was that approximately 10 percent of the proteins in each
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sample were of parasite origin. Proteins were extracted from each sample, normalized for
protein concentration, digested and labeled with TMT-10plex reagent (omitting two
channels) and then pooled together. The set for phosphopeptide analysis were enriched
with tiO2 (or iron iMAC). Both sets were prefractionated using high pH reversed phase
HPLC and individual fractions were analyzed by nanoLC-MS/MS. Relative
phosphorylation site usage in WT and ∆FIKK parasites was analyzed by quantitative
mass spectroscopy. Bioinformatic filtering was used to reduce the site and protein false
discovery rate to less than 1% and 3% respectively. HFF proteins and parasite proteins
were filtered by bioinformatics based on each of their respective genomes and analyzed
separately. Peptides homologous to both HFF and parasite proteins were excluded.
Protein alignment was performed using Scaffold 4.
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Table 6: Experimental Setup for RNA Sequencing and Proteomics
T0(24h no

24h Stress

48h Stress

72h Stress

stress)

(SNP)

PruΔHPT WT2

Triplicate

Triplicate

Triplicate

Triplicate

PruΔHPTΔFIKK

Duplicate

Duplicate

Duplicate

Duplicate

3

Proteomic and Phosphoproteomic
T0(24h no stress)

72h Stress

PruΔHPT WT2

Triplicate

Triplicate

PruΔHPTΔFIKK 3

Duplicate

Duplicate
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Motif Search
Previous analysis of PfFIKK8 and CpFIKK by Osman et al. 2015 determined that
both the FIKK kinases in P. falciparum and C. parvum targeted a protein motif consisting
of seven amino acid residues (RAPSFYR). Based on the sequence a search was
performed using ToxoDB to identify potential FIKK targets based on the presence of this
motif. The search was performed using Perl style regular expression, which allows the
search to be based on specific amino acids with other amino acids being represented by a
number indicating the chemical profile of the amino acid. The motif translated into the
Perl expression was R66S66R indicating the presence of the flanking arginines and
central serine which Osman et al. identified as crucial to the enzymatic activity of the
PfFIKK8 and CpFIKK enzymes (58).

Statistics and Relevant Programs
Statistical analysis was performed using Graphpad Prism 8 based on the
recommendations of the program. After normalization and preliminary analysis by
Cornell or Danforth, files containing genes, log2fold change, and p-values were evaluated
by us. Data mining these files was performed using R Studio (https://rstudio.com/), and
Volcano plots were produced using Glueviz (http://glueviz.org/). Primers were designed
using the NCBI primer design tool (https://www.ncbi.nlm.nih.gov/tools/primer-blast/).
Plasmid maps and alignments were made using Benchling (https://www.benchling.com/),
and images were analyzed using FIJI (https://imagej.net/Fiji). All graphical images were
made using Biorender (https://biorender.com).
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Results
Aim 1: Initial Characterization of the T. gondii FIKK Kinase Gene
Deletion
The FIKK Kinase is Localized to the Basal Complex Throughout the
Parasite’s Lytic Cycle But it is Also Localized to the Host Cell Cytosol.
In previously published studies, the endogenously tagged FIKK protein tagged with YFP
or Ty (FIKK-YFP/FIKK-Ty respectively) localized to the basal end of T. gondii and
colocalized with MORN1 in the parasite basal complex1 (Figure 9) (72). However, a
limitation of these previous studies was that the FIKK-YFP tagged protein required
amplification with both a mouse anti-GFP primary antibody followed by an anti-mouse
goat secondary antibody conjugated with Alexa Flour 488 in order to be visualized by
fluorescence microscopy (Figure 9). Such amplification can increase non-specific
background fluorescent signals. Thus, it was not clear from previous studies whether
parasite expression of FIKK-YFP was exclusive to the parasite basal complex throughout
the parasites’ lytic cycle or whether lower amounts of the protein were localized to other
areas of the parasite or infected host cell. In order to overcome these limitations, live cell
imaging was performed with the RH FIKK-YFP parasite clone using a Nikon Eclipse TiE
florescent microscope. New advances in microscopic imaging with the Nikon Eclipse TiE
system results in greater florescent light capture than the previously utilized Zeiss
inverted Axiovert 200 System. Still images are shown in the first panel in Figure 20. In
the first panel, two extracellular parasites are shown prior to invasion into the adjacent
HFF cell. The FIKK-YFP protein (green) is evident exclusively in the basal end of the
extracellular parasites. In the next panel, a parasite is shown in the process of invasion of
the HFF cell. The constriction within the parasite marks the tight junction/moving
junction that is formed between the parasite and host membrane during parasite invasion.
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It is clear that during parasite invasion the FIKK kinase is unchanged in the parasite basal
end. In the next panel, two parasites are shown that have replicated by endodyogeny and
are linked to one another through their basal ends. The FIKK-YFP protein is associated
with each of the parasite’s basal ends but surprisingly is also evident in the host cell
cytosol surrounding the parasitophorous vacuole (PV). This suggests that the FIKK-YFP
protein may be exported or otherwise traffic from the PV to the infected host cell cytosol,
perhaps transiently, during the parasite’s lytic cycle (Figure 20). The last panel shows 8
parasites/PV in a rosette formation with the FIKK-YFP in the basal end of each parasite.
Thus live-cell imaging of parasites and HFF cells during the parasites’ lytic cycle was
consistent with previous immunofluorescence that showed a continuous localization to
the basal end of the parasite throughout the lytic cycle. However, live-cell imaging
disclosed a previously unknown potential localization of the FIKK-YFP to the host cell
cytosol. The significance and mechanism of FIKK-YFP localization to the host cell
cytosol is beyond the scope of this thesis. However, its potential localization in the host
cell outside of the parasite and its PV must be considered in terms of the potential role of
the FIKK protein during infection.
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Figure 20: Live Cell Imaging of the FIKK-YFP
Part A: Live cell imaging of the parasite expressing FIKK YFP over the course of 36 hour
in HFF cells showing extracellular parasites, parasites invading HFF cells, two parasites
per vacuole and approximately 8 parasites per vacuole. Part B: A single snap shot of an
entire microscope field containing parasites that express FIKK YFP in HFF cells. FIKKYFP can be seen on the basal end of intracellular and extracellular parasites. It is also clear
that there are foci of FIKK-YFP expression in areas that appear to contain few or no
parasites. This suggests that the FIKK-YFP enters host cells that may not contain
parasites.
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Impact of FIKK Gene Deletion on the Global Parasite Transcriptome
and Proteome.
The FIKK gene was deleted in the Type II Pru strain of T. gondii in order to
examine the importance of the FIKK gene in cystogenic parasite strains as well as those
that are the more common agents of toxoplasmosis in humans. In order to evaluate
whether deletion of the FIKK gene impacted the expression of downstream genes we
performed global RNA-sequencing of the intracellular wild type parasite versus the FIKK
gene depleted parasites. RNA sequencing was performed after the creation of first set of
FIKK gene deletions in the clonally purified line of Pru∆HPT. It was unknown how the
FIKK deletion would impact the organism and these molecular techniques allowed us to
cast a wide net and catch any potential differences between wild-type and ∆FIKK
parasites. RNA sequencing was compared between WT parasites and FIKK gene deleted
parasites first in the absence of exogenous stress in intracellular parasites, and then in
response to sodium nitroprusside to evaluate the impact on genes induced in bradyzoiteinducing conditions. Since we used a high multiplicity of infection, exogenous SNP did
not induce cyst formation or pronounced expression of bradyzoite genes. Differentially
expressed genes were compared between WT and ∆FIKK parasites in the presence and
absence of exogenous SNP. A list of differentially expressed genes (DEGs) was created
based on Log2fold changes between wild-type and ∆FIKK clone and adjusted p-values to
take into account false discovery. A volcano plot is shown in Figure 21that shows
differentially expressed genes in intracellular parasites between WT and ∆FIKK clones in
the absence of exogenous stress. A limited set of genes (12) were found to be different
between wild-type and ∆FIKK in the RNA sequencing analysis in non-stressed
conditions. As expected, the expression of the FIKK gene was decreased in the ∆FIKK
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clones and the expression of the HPT gene was increased. However, no definitive pattern
could be found in the limited number of differentially expressed genes, particularly since
many of the changed genes are hypothetical proteins with no annotated functional
domains or function (Figure 21, Figure 22,Figure 23, Figure 24). There was also a minor
difference in gene expression between WT and ∆FIKK clones in the presence of SNP for
24, 48 or 72 hrs. Thus deletion of the FIKK kinase has very minimal impact on parasite
gene expression in tachyzoites.
Global proteomic and phosphoproteomic analysis was performed that compared
intracellular wild type and ∆FIKK clones in the presence and absence of SNP. We were
unable to detect the FIKK protein in these studies which made it clear that the depth of
the study in terms of protein detection in parasites was limited. This is consistent with the
fact that parasite proteins represented potentially less than 10% of total proteins due to
HFF cell numbers compared to parasites. Our analysis showed that when wild-type was
compared to ∆FIKK clones in either the presence or absence of exogenous stress no
proteins met the criteria for differential expression (log2 Fold change of 1.5) and
statistical significance (adjusted p <0.05).
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Product Description

log2FoldChange

padj

HXGPRT

-1.658058295

4.98E-65

hypothetical protein
RNA-dependent RNA
polymerase RDP

-1.579784939

4.23E-52

-1.651995989

1.97E-92

hypothetical protein

-1.484182196

1.77E-33

hypothetical protein
dynein heavy chain
family protein

-1.466494673

5.11E-24

-2.065296607

2.20E-62

hypothetical protein

-1.405118414

1.97E-12

hypothetical protein

-1.47969181

7.04E-16

hypothetical protein

-1.551629019

8.91E-25

hypothetical protein

-1.719097313

2.66E-05

RuvB family 2 protein

-1.796142202

2.34E-110

FIKK kinase, putative

2.044706223

4.67E-07

Figure 21: Differentially Expressed Genes Between Pru∆HPT and ∆FIKK Clones With
No Exogenous Stress
Differential expression of genes between Pru∆HPT and Pru∆HPT∆FIKK3. Twelve genes
were differentially expressed based on an adjusted p value of <0.05 and a Log2 fold
change of at least 1.5. Alignment and analysis was performed using Deqseq with
statistical significance calculated using the Benjamini-hochberg method.
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Product Description

log2FoldChange padj

log10_pvalue

DnAK-TPR

-1.61996

1.48E-33

32.83103

hypothetical protein

-1.91115

4.07E-89

88.39032

RuvB family 2 protein

-1.65839

1.85E-113

112.7322

FIKK kinase, putative

2.852037

1.73E-14

13.76228

Figure 22: Differentially Expressed Genes Between Pru∆HPT and ∆FIKK Clones at 24
Hours Under SNP Stress
Four genes were statistically significant based on an adjusted p value <0.05 Log 2 fold
change of at least 1.5 Alignment and analysis was performed using Deqseq with
statistical significance calculated using the Benjamini-hochberg method.
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Product Description

log2FoldChange

pvalue

HXGPRT

1.72388

3.25E-95

hypothetical protein

-1.80511

3.20E-85

RuvB family 2 protein

-1.6487

4.66E-116

FIKK kinase, putative

2.652368

6.27E-15

Figure 23:Differentially Expressed Genes Between Pru∆HPT and ∆FIKK Clones at 48
Hours Under SNP Stress
Four genes were statistically significant based on an adjusted p value <0.05 Log 2 fold
change of at least 1.5 Alignment and analysis was performed using Deqseq with
statistical significance calculated using the Benjamini-hochberg method.
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Product Description

log2FoldChange

padj

hypothetical protein

-2.35129

3.25E-131

RuvB family 2 protein

-2.15118

1.73E-200

FIKK kinase, putative

3.267567

4.21E-19

Figure 24: Differentially Expressed Genes Between Pru∆HPT and ∆FIKK Clones at 72
Hours Under SNP Stress
Three genes were statistically significant based on an adjusted p value <0.05 Log2 fold
change of at least 1.5 Alignment and analysis was performed using Deqseq with
statistical significance calculated using the Benjamini-hochberg method.
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Aim 2: Functional Characterization of the FIKK Kinase for Acute
Infection
In Aim 1 we attempted to characterize the FIKK deletion by examining the effects
of the FIKK deletion on the global transcriptome and proteome of the parasite. In Aim 2
we evaluated whether the T. gondii FIKK kinase contributes to the lytic cycle of the Type
II strain of the parasite and its ability to cause acute infection.

The FIKK Kinase is Not Required for the Parasites’ Lytic Cycle in vitro.
Localization to the basal end of the parasite in association with the basal complex
suggested a potential role for the FIKK kinase in parasite replication. Our previous study
showed no role for the FIKK kinase in the lytic cycle in Type I RH parasites (72).
However, RH is a lab strain that is extensively adapted for growth as a “professional
tachyzoite”. Thus we evaluated the importance of the FIKK kinase in the lytic cycle of
the Type II Prugnaud (Pru) strain, as unlike RH, Pru remains capable of differentiating
between tachyzoites and bradyzoites in acute versus chronic infection respectively. Thus
the effect of FIKK gene deletion in the Prugnaud strain of T. gondii on parasite
replication and the parasites’ lytic cycle were evaluated. In Aim 2, the parasite’s lytic
cycle in HFF cells as well as individual steps in the parasite’s lytic cycle was compared
between WT, FIKK deleted parasites, and FIKK kinase complemented parasites. of the
parasite lytic cycle (Figure 25).
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Figure 25: Parasite Lytic Cycle
The parasite’s lytic cycle consists of parasite invasion of host cells, formation of a PV,
replication within the host cell PV, and lysis of the host cell releasing the parasites to
reinvade other host cells.
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There is No Gross Impact of the FIKK Gene Deletion on Parasite in
vitro Growth in HFF Cells
The parasite lytic cycle is dependent on parasite gliding motility to reach host
cells, invasion of host cells, replication in the PV, and parasite egress to re-initiate the
lytic cycle in new host cells. Gross defects in T. gondii’s lytic cycle are assessed by
evaluating the ability of the parasite to form plaques in an HFF cell monolayer. The
presence of plaques shows that the parasite can complete multiple sequential rounds of its
lytic cycle. The size of the plaques in the HFF cell monolayer created by each parasite
provides an additional measure of how effectively the parasite completes multiple lytic
cycles in order to create a spreading zone of lysis over time in the HFF cell monolayer.
To compare the lytic cycle of wild type parasites, FIKK gene deleted parasites and FIKK
complemented clones their ability to form comparable plaques in HFF cells was
evaluated. Plaques were compared in both stressed HFF cells as well as non-stressed HFF
cells to evaluate the effect of biological stress on the parasite’s lytic cycle. As shown in
Figure 26 wild type, ∆FIKK and FIKK complemented parasites were all able to form
plaques in HFF cell monolayers. Furthermore, the average size of each plaque, which
reflects the zone of HFF cell lysis over time, was similar for wild type, ∆FIKK and FIKK
complemented parasites. However, in the presence of exogenous stress, also referred to
as bradyzoite-inducing conditions, there was a slight increase in the size of plaques
created by the ∆FIKK clones that was restored in complemented clones. Thus the
deletion of the FIKK gene did not grossly affect the parasites’ lytic cycle in vitro in HFF
cells in the absence of exogenous stress but moderately enhanced the parasite lytic cycle
in bradyzoite-inducing conditions (stressed conditions).
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Pru∆Ku80

Pru∆Ku80∆FIKK

Figure 26: Plaque Sizes of Pru∆Ku80, ∆FIKK, and FIKK Kinase Complemented Clones
A. Plaque areas of clones under standard growth conditions (D10 medium at 37°C) for 57 days. The area of the zone of HFF cell lysis was measured and the mean and SD is
shown. B. Plaque area after growth in bradyzoite inducing conditions (MPA stress for
extracellular parasites for four hours). The area of the zone of HFF cell lysis was
measured and the mean and SD is shown. C. Example of a plaque from Pru∆Ku80 and
∆FIKK clones. Average plaque size was the same in Pru∆Ku80 and ∆FIKK clones in the
absence of exogenous stress; however a slight increase in plaque size was seen in ∆FIKK
parasites grown under stress conditions. Analysis was performed in Graphpad Prism
using a one way ANOVA with Tukey post-hoc test. All clones were compared to each
other. ** p<0.001.
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Deletion of the FIKK Kinase Does Not Impact the Efficiency of Parasite
Invasion of HFF Cells.
It was clear from the plaque assay that both WT and ∆FIKK parasites formed
similar plaques over 5-7 days. However, a plaque assay is unable to identify changes in
the efficiency of parasite invasion; how quickly are parasites able to invade cells. The
efficiency of parasite invasion is determined using an invasion assay, also known as an in
vs out assay. The assay uses a short pulse of parasite challenge of HFF cells and
evaluates how many parasites are able to invade during this short exposure versus how
many remain extracellular. Differential permeabilization is combined with antibody
staining of parasites to differentiate extracellular parasites from intracellular parasites. As
shown in Figure 27, there was no marked deficiency in the invasion efficiency between
the wild-type and ∆FIKK clones.
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Figure 27: Parasite Invasion Assay
Parasite invasion efficiency was determined by measuring the total number of parasites
(green and purple) versus the number of intracellular parasites (purple) after a short HFF
challenge pulse of parasites. The picture shows a florescent microscope field that shows
intracellular parasites (purple) versus total parasites (green and purple). The percent of in
intracellular parasites compared to total parasites is shown in the graph. The statistical
analysis was done using a one way ANOVA with a Tukey post hoc test comparing the
clones to each other. Bars are mean with red error bars showing the 95% Confidence
Interval.
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The FIKK Kinase Does Not Alter Parasite Replication Within a PV
To determine whether the deletion of the FIKK kinase impacted replication of the
Pru strain of T. gondii the number of parasites within parasitophorous vacuoles in HFF
cells were measured over time. Parasite replication was directly measured by comparing
the number of intracellular parasites per PV 24 and 48 hours post-invasion. As shown in
Figure 28, there was no significant difference between WT and FIKK deficient parasites
in terms of parasite replication in the presence or absence of bradyzoite inducing
conditions.
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Figure 28: Parasite Replication of WT and FIKK Deficient Parasites in the Presence and
Absence of Exogenous Stress
A total of 100 vacuoles were counted per clone per time point. Part A clones under
Stressed conditions (MPA treatment), Part B non-stressed. Analysis was done using a one
way ANOVA with a Tukey post hoc test comparing the mean parasite per vacuole
number between the clones. No significant differences were found between the clones.
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The FIKK Kinase is Important for Parasite Virulence During Acute
Infection in vivo
Although the FIKK kinase was not critical for the parasite’s lytic cycle, it is clear
that infection in vivo is more complicated than the lytic cycle in vitro in HFF cells.
Therefore, we evaluated whether the deletion of the FIKK kinase impacted parasite
virulence during acute infection in mice. Three groups of 5 C57BL/6 mice per group
were inoculated intraperitoneally with 200 parasites. The number of viable parasites per
each inoculate was confirmed by plaque assay of parasites in HFF cells after injection of
the mice was complete. Acute infection symptoms manifested within 2 weeks of
infection indicating sickness in all mice. Mice were kept and monitored for 30 days, and
euthanized if they showed moribund behaviors (slow movement, shaking, and cold body
temperature). Mice infected with wild-type parasites were all euthanized on day 8 postinfection as infected mice were all moribund. Mice infected with Pru∆FIKK complement
2 were euthanized on day 9 post-infection as they were all moribund. One mouse infected
with Pru∆FIKK complement 3 was moribund behavior on day 13 post infection and was
sacrificed. The 3 remaining mice were sacrificed on day 14 post-infection when they
became moribund. All of the the mice infected with Pru∆ku80∆FIKK showed symptoms
of infection but subsequently recovered. They survived up to day 30 post infection at
which point they were euthanized at the end of the experiment (Figure 29).
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Figure 29: Survival Curves of Acute Infection
A: Mice were infected IP with 200 parasites. Parasite dose for each clone was confirmed
by counting the number of HFF plaques in a plaque assay. B: Survival curves of mice
infected with WT, ∆FIKK and FIKK complemented clones. Mice infected with ∆FIKK
parasites survived acute infection, recovered and appeared healthy through the 30 days
post-infection. Mice infected with Pru∆Ku80 had a similar mortality to mice infected
with FIKK complement 2. However, complement 3 showed a minor difference in
survival. Statistical analysis was performed using the Log-rank test * p<0.05 *** p<
0.001.
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Aim 3: Functional Characterization of the FIKK Kinase in Chronic
Infection
The FIKK Kinase is Important for Cyst Formation in vitro
In Aim 3 we evaluated whether the T. gondii FIKK kinase contributed to cyst
formation and ultimately chronic infection. Tachyzoite to bradyzoite differentiation as
well as cyst formation can be induced in vitro in HFF cells in response to exogenous
stress. These stresses are typically referred to as bradyzoite-inducing conditions. Wild
type parasites, ∆FIKK parasites and complemented clones were compared to determine if
the FIKK kinase was important for tachyzoite to bradyzoite differentiation and cyst
formation in vitro in HFF cells and in vivo in mice. FIKK gene deletions in the Pru ∆HPT
lines as well as the Pur∆ku80 lines were also compared.
Bradyzoite inducing conditions in vitro include nitric oxide exposure, nutrient
deprivation, alkaline pH stress, and exposure to anti-toxoplasma drugs. We first
determined whether the FIKK kinase contributed to parasite cyst formation in response to
NO (SNP). Three independent gene deletions for the FIKK gene were assessed, two in
the Pru∆HPT parental parasites and one in the Pru∆HPT∆Ku80. Cyst numbers relative to
tachyzoites in PVs was evaluated by florescence microscopy. DBA staining was used to
identify cysts compared to PVs. Cysts were defined as any vacuole positive for CST1
staining with a defined cyst wall around the edge. As shown in Figure 30 and Figure 31,
∆FIKK parasites did not form cysts in the presence of SNP for three days. In contrast,
both WT and FIKK complement parasites readily formed cysts in response to SNP.
To determine whether the deletion of the FIKK kinase was important for a general
conserved pathway important for tachyzoite to bradyzoite differentiation and cyst
formation or just a pathway specific to NO, ∆FIKK parasites were examined to determine
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whether they were impaired for cyst formation induced by a panel of established parasite
bradyzoite/cyst-inducing conditions. As shown in Figures 27 and 28, ∆FIKK parasites
failed to form cysts in response to all of the bradyzoite/cyst-inducing conditions.
Additionally, the impact of FIKK gene deletion on spontaneous cyst formation in the
absence of exogenous stress was all evaluated. ∆FIKK parasites were also unable to
spontaneously convert to cysts in the absence of exogenous inducers of bradyzoites/cysts
(Figure 31).
Initial characterization of the importance of the FIKK kinase in cyst formation
was performed using the PruΔHPTΔFIKK clones and Pru∆Ku80∆FIKK clones. Our
results show that cyst production was impaired for all FIKK gene deleted clones
regardless of the parental clones or bradyzoite/cyst-inducing conditions. We also
compared the the Pru∆Ku80, ∆FIKK, and complemented clones to confirm that deletion
of the FIKK gene prevented cyst formation by parasites and complementation of the
mutants with the FIKK gene restored cyst formation. Complementation of ∆FIKK
parasites restored cyst production in the parasites. (Figure 30, Figure 31, Figure 32).
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Figure 30: Cyst Formation in vitro by Pru∆HPT and Pru∆HPT∆FIKK Clones
Pru∆HPT and ∆FIKK clones were inoculated into HFF cells and stressed using different
conditions for 72 hours. A. Cyst production in response to exogenous SNP; B Cyst
production in response to arginine starvation. Statistical analysis was performed using
ANOVA with a Tukey post hoc test. Comparisons were made between the wild-types
and their respective groups of ∆FIKK clones with the wild-type significantly different
from their ∆FIKK clones, the ∆FIKK clones were not significantly different from each
other. Bars are mean with 95% confidence interval. ** p<0.01
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Figure 31: Cyst Formation in vitro Pru∆Ku80.
Cyst formation was statistically significantly different between Pru∆Ku80 wild-type and
∆FIKK Clones but not between wild-type and complemented clones. Unpaired student’s
T-test was used to compare two clones, a one way ANOVA was used to compare more
than two with a Tukey post hoc test also used to compare groups. Comparisons were made
between wild-type and ∆FIKK clones and when present between wild-type, ∆FIKK, and
complemented clones. The wild-type clone was significantly different from the ∆FIKK
clone, FIKK complements were not different from the wild-type clone. Any statistically
significant differences between clones is annotated with asterisks. Bars are mean with 95%
confidence interval.* p<0.05 **** P<0.0001
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Figure 32: Cysts in vitro
In vitro cyst in HFF cells. A. Pru∆Ku80, B. Pru∆Ku80∆FIKK, C.
Pru∆Ku80∆FIKK + FIKK 1. Cysts are stained green with FITC-DBA,
Parasites are stained red, and counterstained with DAPI.
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The FIKK Kinase is Important for Establishment of Chronic Infection
in Mice
Our results indicate that the FIKK kinase is important for cyst formation in vitro
in HFF cells in response to a variety of known cyst inducing conditions. Thus we
evaluated the importance of the FIKK kinase to the establishment of chronic infection. To
evaluate chronic infection in mice a parasite dose that allows the parasite to survive the
initial acute stage of infection but yet results in significant cyst formation 30 days postinfection must be used. We first compared the two sets of independent FIKK gene
deletion in the Pru∆HPT line wild in CD1 outbred mice. These mice are relatively more
resistant to the acute and chronic stages of infection. Thus, CD1 outbred mice are more
likely to survive acute infection with T. gondii to establish chronic infection. In
independent experiments CD1 outbred mice were challenged ip with either 500 parasites
(Pru∆HPT compared to wild-type 2) or 2000 parasites (Pru∆HPT compared to wild-type
1).
As shown in Figure 33, in one experiment the ∆FIKK clones had significantly
fewer cysts in the brain at 30 days post-infection compared to WT in CDI outbred mice.
In a second experiment ∆FIKK clones also had fewer cysts than WT mice but the result
was not significant. The high standard deviation associated with cyst numbers in mice is
due to the genetic heterogeneity in the CD-1 outbred mice. Therefore, in a subsequent
experiment we used inbred BALB/C mice. In this experiment we compared the Pu∆Ku80
parasites with its respective ∆FIKK and FIKK complemented clones. Mice were
inoculated IP with 200 parasites. 30 days post-infection mice were euthanized and brains
were stained for cysts using florescent-conjugated DBA and examined by florescence
microscopy.
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Figure 33: Infection with ∆FIKK Parasites Results in Decreased Numbers of Brain Cysts
A. Picture of a DBA-stained brain cyst from mice infected with WT parasites. B. Number of
brain cysts following infection of CD1 outbred mice with WT parasites or ∆FIKK clones. C.
Number of brain cysts following infection of CD1 outbred mice with WT parasites and ∆FIKK
clones from an independent electroporation then in B. C. Number of cysts in the brains of
BALB/c mice 30 days post-infection with Pru∆ku80, ∆FIKK clones and FIKK complemented
clones. Analysis was performed using ANOVA with a Tukey test * p<0.05 ** p<0.01 ****
p<0.0001
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The FIKK Kinase is Important for Tachyzoite Differentiation to
Bradyzoites.
Previous experiments showed that removal of the FIKK gene from the genome
negatively affected the parasite’s ability to form cysts both in vitro and in vivo.
Tachyzoite to bradyzoite transition and the resulting production of cysts is a complicated
and multistep process. Transition between stages involves changes in the expression of
more than a thousand genes, production of cyst wall components and their trafficking to
the PVM, remodeling of the PVM to form a nascent cyst wall and inner membrane. In
our previous studies we showed that the FIKK kinase is required for efficient formation
of cysts in response to cyst-inducing conditions. The question remained where in this
process of cyst formation the FIKK kinase is required. First, we evaluated whether the
FIKK kinase was required for one of the earliest steps in cyst production; the initiation of
tachyzoite differentiation to bradyzoites. Thus we evaluated whether parasites deficient
for the FIKK kinase increased their expression of canonical markers specific for
bradyzoites as compared to tachyzoites in response to cyst inducing conditions.
Extracellular WT and ∆FIKK clones were exposed for 4 hours to bradyzoite/cyst
inducing conditions prior to allowing the parasites to invade an HFF cell monolayer.
Bradyzoite/cyst-inducing conditions were maintained in the parasite-infected culture for
24, 48, and 72 hours. Parasites were lysed at each time point, RNA isolated and qRTPCR was performed to evaluate the expression of a panel of canonical bradyzoite genes
Bag1 which is a surface marker of bradyzoites, LDH2, and ENO1 metabolic genes
expressed in bradyzoites, and cyst wall proteins CST1, BPK1, and MCP4. We found a
marked reduction in the expression of bradyzoite associated genes in the
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Pru∆HPT∆FIKK and similar, though not as sharp, reduction in bradyzoite markers in
Pru∆Ku80∆FIKK that returned to the wild-type baseline in the complements (Figure 34)
These results indicated a role for the TgFIKK in regulating these genes. Since it was clear
that the ∆FIKK parasites were impaired for tachyzoite to bradyzoite differentiation, we
evaluated early events associated with entry of tachyzoites into the bradyzoite
differentiation pathway at the G1 cell cycle checkpoint. The current determinants that are
important for entry into the bradyzoite differentiation pathway are unknown, but we
examined expression of members of the Ap2 transcription factors that have been shown
to be important in the process of tachyzoite to bradyzoite differentiation. We examined
the expression of the Ap2 transcription factors over time in Pru∆Ku80 line and the clones
made from it. We examined the expression at a baseline (4 hours extracellularly) to 24,
48, and 72 hours under stress (MPA stress) to examine if there was a difference in
expression under bradyzoite inducing conditions. The factors examined were a series
known to be involved in tachyzoite to bradyzoite transition (Figure 35, Figure 36). We
found only a minor difference of expression in two factors in the ∆FIKK line Ap2IX-4 at
48 hours, and Ap2IV-3 at 4 hours.
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Figure 34: Expression of Canonical Bradyzoite Marker in WT versus ∆FIKK Parasites
Cultured in Bradyzoite/cyst-inducing Conditions.
Expression of canonical bradyzoite associated markers in WT versus ∆FIKK parasites.
qRT-PCR was performed with primers listed in Table 5 for each gene. Expression was
normalized using the housekeeping gene tubulin (Tub1) and quantified using the ∆∆Ct
method. Parts A-C Pru∆Ku80∆FIKK and FIKK complement compared to Pru∆Ku80
wild-e type at 24, 48, and 72 hours post-infection. Part D. Pru∆Hpt and Pru∆HPT∆FIKK
compared at 72 hours post-infection.
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Figure 35: Expression of Ap2 Transcription Factors in WT Parasites, ∆FIKK Clones and
FIKK Complemented Parasites
Differential expression of these Ap2 transcription factors in tachyzoites and bradyzoites
are associated with stage differentiation. Plots are the ∆Ct for the various genes,
expression normalized to Tub1, at different time points under stress conditions (MPA
treatment).
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Figure 36: Expression of Ap2 Transcription Factors in WT Parasites, ∆FIKK Clones
and FIKK Complemented Parasites
Differential expression of these Ap2 transcription factors in tachyzoites and
bradyzoites are associated with stage differentiation. Plots are the ∆Ct for the various
genes, expression normalized to Tub1, at different time points under stress conditions
(MPA treatment)
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FIKK Target Search
The sequence targeted for phosphorylation by TgFIKK are currently unknown.
The two closest homologous to TgFIKK are P. falciparum FIKK 8 and the FIKK kinase
in Cryptosporidium parvum (Figure 37). While the TgFIKK is significantly larger than
either of the homologs in Plasmodium falciparum and Crytosporidium parvum, the three
proteins have a high degree of homology at the C terminal ends where the kinase domain
is located. Previous studies have determined a motif targeted by both CpFIKK and
PfFIKK8 (58). We performed a search in ToxoDB.org for proteins containing this motif.
59 genes were found to contain this protein motif in the T. gondii genome. While most
are hypothetical proteins a few known transcription, factors were discovered including
four known Ap2 transcription factors (Ap2VIII-2, Ap2XII-4, Ap2III-2, and Ap2IX-9)
Ap2IX-9 is known to be important for bradyzoite differentiation. While annotated as a
repressor or bradyzoite associated genes Ap2IX-9 expression increases during stage
differentiation and is theorized to keep the parasite in a “holding pattern” during the
transition (56). (Table 7).
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Figure 37: Alignment of TgFIKK, PfFIKK8, PfFIKK8 Active site, and CpFIKK
Alignment of the TgFIKK, PfFIKK8, CpFIKK, proteins, and the PfFIKK8 active site.
The TgFIKK is significantly longer than the other two FIKK proteins while all three
proteins have a high degree of homology at the C-terminus. The three proteins have a
33% pairwise identity. The catalytic kinase domain is intact in all three of the proteins.
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Table 7: Genes in the T. gondii Genome that Contain the Putative FIKK Target Sequence
Gene.ID

Product. Description

TGME49_202070

hypothetical protein

TGME49_204380

hypothetical protein

TGME49_208400

hypothetical protein

TGME49_208710

DNA/RNA non-specific endonuclease

TGME49_209510

hypothetical protein

TGME49_209850

RNA recognition motif-containing protein

TGME49_212130

phospholipase, patatin family protein

TGME49_214900

hypothetical protein

TGME49_215370

hypothetical protein

TGME49_217490

hypothetical protein

TGME49_217855

hypothetical protein

TGME49_218550

PIK3R4 kinase-related protein

TGME49_223550

hypothetical protein

TGME49_225090

hypothetical protein

TGME49_226280

ribosomal protein L28, putative

TGME49_227000

hypothetical protein

TGME49_228380

hypothetical protein

TGME49_232240

hypothetical protein

TGME49_233120

Ap2 domain transcription factor Ap2VIII-2

TGME49_234200

hypothetical protein

TGME49_238970

hypothetical protein

TGME49_239420

protein kinase

TGME49_240370

Toxoplasma gondii family E protein

TGME49_243970

hypothetical protein

TGME49_247700

Ap2 domain transcription factor Ap2XII-4

TGME49_252870

hypothetical protein

TGME49_253440

cell-cycle-associated protein kinase SRPK, putative

TGME49_260640

autophagy protein apg9 protein

TGME49_261490

hypothetical protein

TGME49_261610

hypothetical protein

TGME49_262950

hypothetical protein

TGME49_263610

hypothetical protein

TGME49_264670

DNA polymerase family B protein

TGME49_266930

general transcription factor IIH polypeptide 3 GTF2H3

TGME49_268020

transporter, major facilitator family protein

TGME49_268035

hypothetical protein

TGME49_268370

non-specific serine/threonine protein kinase

TGME49_270060

hypothetical protein
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TGME49_270720

hypothetical protein

TGME49_270930

hypothetical protein

TGME49_270940

hypothetical protein

TGME49_285230

PRP38 family protein

TGME49_288420

hypothetical protein

TGME49_289280

hypothetical protein

TGME49_292300

DNA-directed RNA polymerase III RPC8

TGME49_299150

Ap2 domain transcription factor Ap2III-3

TGME49_305640

metallo-beta-lactamase domain-containing protein

TGME49_306400

hypothetical protein

TGME49_306620

Ap2 domain transcription factor Ap2IX-9

TGME49_307570

glycerol-3-phosphate dehydrogenase (gpdh), putative

TGME49_312420

hypothetical protein

TGME49_313030

hypothetical protein

TGME49_313140

isocitrate dehydrogenase

TGME49_313270

hypothetical protein

TGME49_313590

hypothetical protein

TGME49_314055

splicing factor, putative

TGME49_315810

tRNA nucleotidyltransferase/poly(A) polymerase family protein

TGME49_315950

zinc finger, C3HC4 type (RING finger) domain-containing protein

TGME49_326500

hypothetical protein
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Figure 38: Schematic Model of the Current Model of Where and How the FIKK Kinase
Functions in Parasite Cyst Formation.
Normal parasites (top row) with the FIKK localized to the basal end of the parasite (red
dot) invade and form PVs with residual bodies linking the parasites together at the basal
end. This residual body forms a bridge to synchronize the parasite through cell-cell
communication. During stage differentiation this bridge is lost as parasites transition to
bradyzoites. The FIKK deleted parasites (bottom row) and invade and form PVS with
residual body linkages, however something is lost during the transition process. Perhaps
the ability to desynchronize, or the loss of an ability to signal between the parasites
necessary to start the transition.
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Discussion
FIKK kinases are a unique family of kinases specific for the Apicomplexa. Most
Apicomplexa parasites have a single FIKK kinase but the family is enlarged in
Plasmodium falciparum and absent in the piroplasms. The function of the FIKK kinases
in the Apicomplexa is poorly understood. However, in Plasmodium they have been
implicated in cytoskeletal alterations in infected red blood cells, particularly in
erythrocyte membranes. FIKK kinases in Plasmodium falciparum, and Crytosporidium
parvum have been shown to have serine threonine phosphorylation activity. Preliminary
data from another laboratory has shown the T. gondii FIKK kinase also has kinase
activity. However, to date our labs and others have been unable to purify the T. gondii
FIKK kinase catalytic domain as it appears to be unstable and prone to degradation (data
not shown).
In a previous study, our laboratory performed an initial characterization of the T.
gondii FIKK kinase in the virulent RH strain of the parasite. This is a lab-adapted strain
originally purified from an infected person that is adapted to growth as a tachyzoite in
cell culture. The RH strain is extremely virulent in mice; a single parasite is lethal in 6-10
days. Endogenous tagging of the 3’ end of the RH-FIKK kinase with YFP revealed it
localized to the basal complex of the parasite in association with the basal complex
protein MORN1. A YFP-tagged FIKK protein and a Ty-tagged FIKK protein both
localized to the parasite basal complex apical to inner membrane complex protein-5 and
Centrin-2. The basal complex is an organelle that is critical for parasite replication (4,
26). MORN-1 in the parasite complex is critical for the formation of a basal contractile
ring that is important to segregate daughter cells during endodyogeny. However MORN1
and the basal complex is also present in mature parasites suggesting a possible role in
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addition to daughter cell formation and segregation (26). Deletion of the FIKK kinase in
the RH strain did not impact parasite replication (72). This may not be surprising because
unlike the basal complex protein MORN1 and other known basal complex proteins, the
FIKK kinase only localizes to the basal complex of mature parasites and it is not found in
daughter cells during parasite division by endodyogeny (72).
The goal of the current study was to evaluate the importance of the T. gondii
FIKK kinase in a parasite strain that remained capable of completing the parasite
mammalian cycle that includes replication as a tachyzoite during acute infection and
stage differentiation to bradyzoites contained in tissue cysts to establish chronic infection.
The Type II genotype T. gondii strains are the most common cause of toxoplasmosis in
humans (13). They are virulent in mice but are often called avirulent because they are less
virulent than the Type I genotypes of the parasite that includes the RH strain. Thus we
deleted the FIKK gene in the Type II genotype Prugnaud strain of T. gondii and
examined the effect on the parasite’s lytic cycle, differentiation from tachyzoites to
bradyzoites to form encysted parasites and during acute and chronic infection in mouse
models of toxoplasmosis. We also complemented the ΔFIKK clones with the FIKK
kinase expressed under the control of its endogenous promoter as a transgene integrated
into the parasite UPT locus. Our studies show the T. gondii FIKK kinase is important for
the ability of the parasite to initiate stage differentiation from tachyzoites to bradyzoites.
Parasites deficient for the FIKK kinase are impaired for cyst production both in vitro in
cell culture in response to exogenous bradyzoite/cyst-inducing conditions and in vivo in
mice.
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TgFIKK is Not Important for the Parasite’s Lytic Cycle
Our study indicates no significant role for TgFIKK in parasite replication in either
the virulent RH strain that replicates primarily as a tachyzoite or the less virulent
Prugnaud strain that retains its ability to interconvert between tachyzoites and
bradyzoites. Deletion of the FIKK gene did not have a significant effect on the parasite’s
lytic cycle in HFF cells as determined by plaque assays in vitro. Furthermore, studies
focused on specific steps in the parasite’s lytic cycle including efficient parasite invasion,
and replication revealed no significant defect in ΔFIKK parasites.

ΔFIKK Parasites Retain Growth Characteristics of Tachyzoites When
Exposed to Bradyzoite-differentiation Conditions.
A difference in plaque size was found with the ΔFIKK clone producing larger plaques
under exogenous bradyzoite-inducing conditions stress. In contrast, no difference was
seen in plaque size in no stress conditions. Our interpretation of these data in light of our
other findings, is that the ΔFIKK parasites remain as tachyzoites in bradyzoite-inducing
conditions. Thus the ability to persist as replication-competent tachyzoites instead of
differentiation into slow-growing bradyzoites, results in increased plaque size in HFF
cells in bradyzoite-inducing conditions (Figure 26)

The TgFIKK Kinase Has a Moderate Impact on Acute Infection in Mice
The acute infection in mice is mediated by the tachyzoite stage of the parasite.
Our studies show that the deletion of the FIKK kinase does impact acute infection with T.
gondii in the mouse model. C57BL/6 mice infected with wild type or FIKK
complemented parasites died during acute infection. In contrast, none of the mice
infected with the ΔFIKK parasites died during acute infection, although they did
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transiently exhibit sick behavior including ruffled fur. It is unclear whether the reason
that the ΔFIKK parasite is less lethal during acute infection is a consequence of their
impaired cyst production or some other undiscovered defect in parasite fitness in vivo.
Other studies have shown that cyst formation can occur as early as 1-day post-infection
(12); thus it is possible that tachyzoite differentiation to bradyzoites and even cyst
formation may alter the host immune response or the parasite during acute infection. This
would certainly align with our other data that showed a marked deficiency in cyst
formation. However, the mice were carefully monitored for signs of sickness over the
course of the experiment, with all the mice showing symptoms around day 7 postinfection. This would indicate that all of the mice, including those infected with the
ΔFIKK clones, developed a systemic and symptomatic infection. However, only the mice
infected with the ∆FIKK clone were able to resolve the symptoms of acute infection and
recover.
It is also possible that the ΔFIKK parasites were less virulent during acute
infection because they retain surface proteins and other immunogenic proteins associated
with tachyzoites since they are impaired for differentiation from tachyzoites to
bradyzoites. Tachyzoites, unlike bradyzoites, generate a robust cell-mediated immune
response that may be important for the parasite to avoid killing its host during acute
infection. T. gondii parasites need to replicate during acute infection and disseminate
systemically in order to establish a chronic infection that can transmit the parasite
through carnivorism. Thus the parasite has evolved mechanisms that enable robust
replication and dissemination but also stimulates a cell-mediated immune response that
most often prevents lethal acute infection. In contrast, to tachyzoites, bradyzoites appear
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to be less immune-stimulatory, and bradyzoites contained in tissue cysts are largely nonimmunogenic. Since the ∆FIKK parasites cannot transition to bradyzoites properly, the
prolonged tachyzoite stage may result in a more potent clearance of parasites by the
increased stimulatory effect on host immunity. Studies have shown that constitutive
expression of certain T. gondii proteins during infection can have a strong immunogenic
effect. One of these immune stimulatory genes is the tachyzoite marker Sag1(59). It is
also possible the ΔFIKK parasites may have dysregulation in tachyzoite and bradyzoite
genes that alter either parasite fitness or immunity. Studies of the Ap2 transcription
factors, particularly Ap2IV-3, and Ap2IX-4 have speculated on the paradoxical nature of
how a “bradyzoite repressor” can be upregulated during tachyzoite to bradyzoite stage
differentiation. The current working hypothesis is that the transition is a carefully
regulated process in which the parasite can produce many highly immunogenic proteins
that cannot be safely expressed until the bradyzoite transition is complete and proper
mature cysts have been formed (64). That dysregulation of this process may result in the
expression of “late bradyzoite genes” far earlier than the parasite needs and that this
could actually increase the immune response of the host. The list of known bradyzoite
genes is long, with ~1000 genes known to be changed between tachyzoites and
bradyzoites. So our results are by no means exhaustive, and it is still possible that some
genes are being expressed in a dysregulated manner in our ∆FIKK clones that could
cause the mutant parasites to be cleared more easily by the host. While such a
dysregulation is possible, we have not seen any unusual expression of bradyzoiteassociated genes when their expression was studied over time (Figure 34). It would seem
based on our results that the ∆FIKK parasites are not initiating an early step important for
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tachyzoite to bradyzoite differentiation, and in some way, this is moderately impacting
fitness during acute infection.

TgFIKK is Important for Early Events that Regulate Tachyzoite to
Bradyzoite Differentiation.
Our results indicate that the FIKK kinase is important for a conserved pathway
that results in cyst formation in response to all known exogenous mediators that induce
cyst formation. The ΔFIKK clones showed a marked reduction in cyst formation in vitro
for all exogenous stress conditions that were tested. Furthermore, the ΔFIKK parasites
were also impaired for spontaneous cyst formation (Figure 30, Figure 31). We concluded
from these experiments that the FIKK kinase is important in the cyst formation process
irrespective of the presence or source of exogenous stress.
The process of cyst formation from tachyzoites is a stepwise process in which the
parasite has to change its epigenetic profile and gene expression, followed by the
expression of necessary genes for bradyzoites and cysts, and then the trafficking of
components for the cyst wall out of the parasite and to the PVM where they can be
assembled into the cyst wall. We first considered a role for the FIKK kinase in
assembling the cyst wall based on previous studies that suggest the presence of a pore in
the posterior end of the parasite. The parasite intramembrane complex (IMC) is located
just beneath the plasma membrane from the anterior to the posterior poles of the parasite.
It is interrupted only by a micropore (MP) located in the posterior end of the parasite near
or part of the parasite basal complex. This pore is believed to be the primary portal
through which secretion of vesicles necessary to form the intracyst network, and possibly
the cyst wall, takes place (71). Electron micrographs have shown the presence of
membrane bound vesicles being trafficked out of the posterior end of the parasite These
116

membrane bound vesicles appear to contain proteins similar to those in the cyst matrix
and ultimately the cyst wall (71). Also a tubular vesicular network called the IVN that
links the parasite and PV membrane has been shown to be associated with the posterior
end of the parasite (38, 55). Thus far we have no definitive data that rigorously proves or
disproves a potential role for the parasite basal complex or FIKK kinase in the structure
or function of this posterior pore. No qualitative difference could be seen between the
few cysts formed by the ΔFIKK clones and the wild-type and FIKK complement clones.
We also evaluated whether ΔFIKK parasites appeared blocked in a step directly related to
cyst wall formation. However, there was no evidence that ΔFIKK parasites created partial
cyst walls or accumulated cyst wall products in the PV that failed to be exported to a
nascent cyst wall (data not shown). Thus we currently have no evidence that the FIKK
kinase is important for the export of cyst wall components to form a nascent cyst wall.
During our initial study of the Pru∆HPT∆FIKK we examined the expression of Ap2
transcription factors and bradyzoite associated genes at 72 hours under stress conditions
and found that the ∆FIKK clones had an expression profile more like that of tachyzoites
than like bradyzoites (Figure 35, Figure 36). These differences supported the hypothesis
that the ∆FIKK clones were not capable of transitioning into the bradyzoite stage. Thus
we compared wild type, Pru∆Ku80, the ∆FIKK clone and the FIKK complements in
bradyzoite/cyst-inducing conditions to determine how early ΔFIKK parasites showed a
difference in the expression of tachyzoite and bradyzoite genes known to be involved in
tachyzoite bradyzoite interconversion. The three-best studied Ap2 genes known to be
involved in cyst formation are Ap2IV-3, Ap2IX-4, and Ap2IX-9. We compared the
change in expression of these genes by qRT-PCR at key time points after exposure of

117

wild type, ΔFIKK and FIKK complemented parasites to bradyzoite/cyst-inducing
conditions (Figure 35, Figure 36), and evaluated our results against the known functions
of these AP2 transcription factors in regulation of tachyzoite to bradyzoite differentiation.
We examined expression from an extracellular time point without stress, compared to 24,
48, and 72 hours post-infection after 4 hours of external MPA/CO2 starvation stress in
order to induce differentiation to bradyzoites. We had hoped that by comparing the
normalized expression values (∆Ct) of the genes between the clones over time some
pattern could be seen in which the ∆FIKK clone would be different from the wild-type
and complement clones. A modest difference unique to the ΔFIKK parasites was found at
the 4 hour extracellular time point for Ap2IV-3. Interestingly Api2IV-3 is considered an
activator of bradyzoite transition and so its higher level earlier in wild type and FIKK
complement parasite clones suggest that in the absence of the FIKK kinase parasites may
respond to exogenous signals that trigger tachyzoite to bradyzoite differentiation or that
parasites are impaired for entry into the bradyzoite differentiation pathway. The ∆FIKK
clone also differs in its expression of Ap2IX-4 at 48 hours. Its expression is decreased in
the ΔFIKK clone, like wild type and FIKK complement parasites in intracellular parasites
exposed to bradyzoite-inducing conditions. However, its expression is elevated at 48
hours only in ΔFIKK parasites. Ap2IX-4 is considered a bradyzoite repressor and a
falloff in expression of this factor is important for the parasite to enter into the process.
This may suggest that the ∆FIKK parasites may be impaired for entry into the bradyzoite
differentiation process but may also upregulate its expression of Ap2IX-4 in prolonged
bradyzoite-inducing conditions. Although preliminary, these studies suggest that the
FIKK kinase may play a multifactorial role in maintaining the parasite as a tachyzoite and

118

preventing its entry into a bradyzoite differentiation pathway. It is worth noting that we
examined expression at the AP2s at the transcript level and many published studies used
tagged forms of the AP2 transcription factors to evaluate protein expression. Recently a
master regulator of bradyzoite transition called BFD1 has been identified (87). We
attempted to detect this gene by qRT-PCR but could not find a difference between the
Pru∆Ku80 wild-type and ∆FIKK clones.
RNA sequencing was performed to determine if there were significant differences
between the wild-type PruΔHPT and ΔFIKK clones. Based on a cutoff of 1.5 fold
differential expression and an adjusted p value of less than 0.05, it was very clear that
deletion of the FIKK kinase did not strongly impact global gene expression during
normal in vitro growth conditions in cell culture in HFF cells. Fewer than 10 genes had
differential expression in the ΔFIKK clones compared to WT. Most genes that were
differentially expressed between WT and ΔFIKK clones are annotated as hypothetical
proteins. Thus we are unable to currently prioritize the changes based on gene annotation
or function domains that might inform function. The only consistently different gene at
all time points was RuvB2 which is a component of the holiday junction important for
homologous directed repair, a pathway in T. gondii upregulated in the tachyzoite stage
(27). No genes were found to be different in the proteomic and phosphoproteomic data
for the wild type and ΔFIKK parasites in the absence of exogenous stress. However, we
were unable to purify the parasite and PV from the HFF cells and thus the depth of
detection of proteins and phosphorylated proteins was limited. Consistent with a lack of
sufficient depth for the proteomics study, the FIKK kinase was not present in the
proteome or phosphoproteome data.
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The exact mechanism of how the FIKK kinase contributes to tachyzoite to
bradyzoite differentiation is unknown. The FIKK kinase substrates or associated proteins
are also unknown. Another group (58) has identified potential protein targets of the
closest homologous to TgFIKK in Plasmodium and Cryptosporidium. These FIKK8
homologs identified a motif consisting of a serine with arginine residues at the +3 and -3
positions with two hydrophobic amino acids in between as being a potential target. A
search of the T. gondii genome database (ToxoDB) using a motif search based on this
residue sequence identified 59 hits that were found to be positive for this motif. Three
Ap2 transcription factors were in this list, Ap2XII-4, Ap2III-3, and Ap2IX-9. Ap2IX-9 is
a repressor of bradyzoite genes (64). However we could not find information about the
other Ap2 transcription factors. Most of the genes on the list are hypothetical proteins.
However some have been annotated with at least one being a zinc finger containing
protein which are known to bind DNA however no information on this protein could be
found.

The FIKK Kinase is Important for Chronic Infection.
Our comparison of chronic infection with wild type, ΔFIKK and FIKK
complement parasite clones revealed that the FIKK kinase was important for the presence
of cysts in the brain of infected mice 30 days post-infection. However, the studies show
that cysts can still form in the absence of the FIKK kinase, but the number is dramatically
reduced both in vitro and in vivo during chronic infection. The low number of cysts in the
brains of infected mice is likely a reflection of the inefficiency of tachyzoite to bradyzoite
differentiation and cyst formation in the absence of the FIKK gene. However it is also
possible that fitness defects associated with the deletion of the FIKK kinase during acute
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infection may also impact the number of brain cysts. A comparison of parasite numbers
in tissues over the time course of acute and chronic infection is needed to ultimately
dissect differences during acute or chronic infection.
In summary our studies have shown that the FIKK kinase in T. gondii is critical
for tachyzoite to bradyzoite differentiation as well as cyst formation in vitro and in vivo
during chronic infection. However, a role for the FIKK kinase in other aspects of cyst
formation cannot be ruled out. Our studies also suggest that the deletion of the FIKK
kinase also impacts parasite fitness during acute infection, that may be dependent or
independent of the host immune response. The FIKK complement clones that were
created have both an HA and BirA tag in the 3’ end of the protein. Both of these tags will
be useful in future studies to identify other proteins that either directly interact with the
FIKK kinase or are near neighbors. The fact that we were able to identify a process for
successful complementation of the ΔFIKK clones with the FIKK kinase also will allow
us to mutate important putative catalytic residues in the FIKK kinase to definitively show
whether FIKK kinase activity is critical for its role in tachyzoite to bradyzoite
differentiation. If the kinase residues are critical, future studies will identify proteins
phosphorylated by the FIKK kinase both in the present and absence of exogenous stress.
Our current working hypothesis is that the FIKK kinase phosphorylates/associates with a
subset of distinct proteins in the basal complex of mature parasites, this
association/regulation of these proteins is important for the transition to bradyzoites,
which involves de-linking and desynchronization of the parasite before the transition to
bradyzoites (Figure 38). On a larger scale, our data suggest the the parasite basal complex
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in mature parasites may have direct functions that regulation stage differentiation in
addition to its known role in parasite endodyogeny.
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